<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.2 20190208//EN"  "JATS-archivearticle1-mathml3.dtd"><article article-type="research-article" dtd-version="1.2" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn pub-type="epub" publication-format="electronic">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">68049</article-id><article-id pub-id-type="doi">10.7554/eLife.68049</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Short Report</subject></subj-group><subj-group subj-group-type="heading"><subject>Stem Cells and Regenerative Medicine</subject></subj-group></article-categories><title-group><article-title>Mesenchymal stromal cell aging impairs the self-organizing capacity of lung alveolar epithelial stem cells</article-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes" id="author-228761"><name><surname>Chanda</surname><given-names>Diptiman</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-4835-4460</contrib-id><email>dchanda@uab.edu</email><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con1"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-229878"><name><surname>Rehan</surname><given-names>Mohammad</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="con2"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-229879"><name><surname>Smith</surname><given-names>Samuel R</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con3"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-229880"><name><surname>Dsouza</surname><given-names>Kevin G</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con4"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-229881"><name><surname>Wang</surname><given-names>Yong</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con5"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-229882"><name><surname>Bernard</surname><given-names>Karen</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con6"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-229883"><name><surname>Kurundkar</surname><given-names>Deepali</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con7"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-229884"><name><surname>Memula</surname><given-names>Vinayak</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="con8"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-229885"><name><surname>Kojima</surname><given-names>Kyoko</given-names></name><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="fn" rid="con9"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-229886"><name><surname>Mobley</surname><given-names>James A</given-names></name><xref ref-type="aff" rid="aff5">5</xref><xref ref-type="other" rid="fund6"/><xref ref-type="fn" rid="con10"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-229887"><name><surname>Benavides</surname><given-names>Gloria A</given-names></name><xref ref-type="aff" rid="aff6">6</xref><xref ref-type="fn" rid="con11"/><xref ref-type="fn" rid="conf2"/></contrib><contrib contrib-type="author" id="author-229888"><name><surname>Darley-Usmar</surname><given-names>Victor</given-names></name><xref ref-type="aff" rid="aff6">6</xref><xref ref-type="fn" rid="con12"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-229889"><name><surname>Kim</surname><given-names>Young-iL</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff7">7</xref><xref ref-type="fn" rid="con13"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-229890"><name><surname>Zmijewski</surname><given-names>Jaroslaw W</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="fund5"/><xref ref-type="fn" rid="con14"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-229891"><name><surname>Deshane</surname><given-names>Jessy S</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="fund7"/><xref ref-type="other" rid="fund8"/><xref ref-type="fn" rid="con15"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-80717"><name><surname>De Langhe</surname><given-names>Stijn</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0003-3867-4572</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con16"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-229892"><name><surname>Thannickal</surname><given-names>Victor J</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0003-4266-8677</contrib-id><email>vthannickal@tulane.edu</email><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="other" rid="fund1"/><xref ref-type="other" rid="fund2"/><xref ref-type="other" rid="fund3"/><xref ref-type="other" rid="fund4"/><xref ref-type="other" rid="fund5"/><xref ref-type="fn" rid="con17"/><xref ref-type="fn" rid="conf1"/></contrib><aff id="aff1"><label>1</label><institution>Division of Pulmonary, Allergy, and Critical Care Medicine, Department of Medicine</institution><addr-line><named-content content-type="city">Birmingham</named-content></addr-line><country>United States</country></aff><aff id="aff2"><label>2</label><institution>John W. Deming Department of Medicine, Tulane University School of Medicine</institution><addr-line><named-content content-type="city">New Orleans</named-content></addr-line><country>United States</country></aff><aff id="aff3"><label>3</label><institution>Department of Surgery</institution><addr-line><named-content content-type="city">Birmingham</named-content></addr-line><country>United States</country></aff><aff id="aff4"><label>4</label><institution>Comprehensive Cancer Center Mass Spectrometry &amp; Proteomics Shared Facility</institution><addr-line><named-content content-type="city">Birmingham</named-content></addr-line><country>United States</country></aff><aff id="aff5"><label>5</label><institution>Department of Anesthesiology and Perioperative Medicine</institution><addr-line><named-content content-type="city">Birmingham</named-content></addr-line><country>United States</country></aff><aff id="aff6"><label>6</label><institution>Department of Pathology</institution><addr-line><named-content content-type="city">Birmingham</named-content></addr-line><country>United States</country></aff><aff id="aff7"><label>7</label><institution>Division of Preventive Medicine, Department of Medicine; University of Alabama at Birmingham</institution><addr-line><named-content content-type="city">Birmingham</named-content></addr-line><country>United States</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor"><name><surname>Noble</surname><given-names>Paul W</given-names></name><role>Reviewing Editor</role><aff><institution>Cedars-Sinai Medical Centre</institution><country>United States</country></aff></contrib><contrib contrib-type="senior_editor"><name><surname>Noble</surname><given-names>Paul W</given-names></name><role>Senior Editor</role><aff><institution>Cedars-Sinai Medical Centre</institution><country>United States</country></aff></contrib></contrib-group><pub-date date-type="publication" publication-format="electronic"><day>16</day><month>09</month><year>2021</year></pub-date><pub-date pub-type="collection"><year>2021</year></pub-date><volume>10</volume><elocation-id>e68049</elocation-id><history><date date-type="received" iso-8601-date="2021-03-03"><day>03</day><month>03</month><year>2021</year></date><date date-type="accepted" iso-8601-date="2021-08-20"><day>20</day><month>08</month><year>2021</year></date></history><pub-history><event><event-desc>This manuscript was published as a preprint at bioRxiv.</event-desc><date date-type="preprint" iso-8601-date="2021-03-07"><day>07</day><month>03</month><year>2021</year></date><self-uri content-type="preprint" xlink:href="https://doi.org/10.1101/2021.03.05.434121"/></event></pub-history><permissions><copyright-statement>© 2021, Chanda et al</copyright-statement><copyright-year>2021</copyright-year><copyright-holder>Chanda et al</copyright-holder><ali:free_to_read/><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><ali:license_ref>http://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-68049-v1.pdf"/><self-uri content-type="figures-pdf" xlink:href="elife-68049-figures-v1.pdf"/><abstract><p>Multicellular organisms maintain structure and function of tissues/organs through emergent, self-organizing behavior. In this report, we demonstrate a critical role for lung mesenchymal stromal cell (L-MSC) aging in determining the capacity to form three-dimensional organoids or ‘alveolospheres’ with type 2 alveolar epithelial cells (AEC2s). In contrast to L-MSCs from aged mice, young L-MSCs support the efficient formation of alveolospheres when co-cultured with young or aged AEC2s. Aged L-MSCs demonstrated features of cellular senescence, altered bioenergetics, and a senescence-associated secretory profile (SASP). The reactive oxygen species generating enzyme, NADPH oxidase 4 (Nox4), was highly activated in aged L-MSCs and Nox4 downregulation was sufficient to, at least partially, reverse this age-related energy deficit, while restoring the self-organizing capacity of alveolospheres. Together, these data indicate a critical role for cellular bioenergetics and redox homeostasis in an organoid model of self-organization and support the concept of thermodynamic entropy in aging biology.</p></abstract><abstract abstract-type="executive-summary"><title>eLife digest</title><p>Many tissues in the body are capable of regenerating by replacing defective or worn-out cells with new ones. This process relies heavily on stem cells, which are precursor cells that lack a set role in the body and can develop into different types of cells under the right conditions. Tissues often have their own pool of stem cells that they use to replenish damaged cells. But as we age, this regeneration process becomes less effective.</p><p>Many of our organs, such as the lungs, are lined with epithelial cells. These cells form a protective barrier, controlling what substances get in and out of the tissue. Alveoli are parts of the lungs that allow oxygen and carbon dioxide to move between the blood and the air in the lungs. And alveoli rely on an effective epithelial cell lining to work properly.</p><p>To replenish these epithelial cells, alveoli have pockets, in which a type of epithelial cell, known as AEC2, lives. These cells can serve as stem cells, developing into a different type of cell under the right conditions. To work properly, AEC2 cells require close interactions with another type of cell called L-MSC, which supports the maintenance of other cells and also has the ability to differentiate into several other cell types. Both cell types can be found close together in these stem cell pockets. So far, it has been unclear how aging affects how these cells work together to replenish the epithelial lining of the alveoli.</p><p>To investigate, Chanda et al. probed AEC2s and L-MSCs in the alveoli of young and old mice. The researchers collected both cell types from young (2-3 months) and aged (22-24 months) mice. Various combinations of these cells were grown to form 3D structures, mimicking how the cells grow in the lungs.</p><p>Young L-MSCs formed normal 3D structures with both young and aged AEC2 cells. But aged L-MSCs developed abnormal, loose structures with AEC2 cells (both young and old cells). Aged L-MSCs were found to have higher levels of an enzyme (called Nox4) that produces oxidants and other ‘pro-aging’ factors, compared to young L-MSCs. However, reducing Nox4 levels in aged L-MSCs allowed these cells to form normal 3D structures with young AEC2 cells, but not aged AEC2 cells.</p><p>These findings highlight the varying effects specific stem cells have, and how their behaviour is affected by pro-aging factors. Moreover, the pro-aging enzyme Nox4 shows potential as a therapeutic target – downregulating its activity may reverse critical effects of aging in cells.</p></abstract><kwd-group kwd-group-type="author-keywords"><kwd>Aging</kwd><kwd>senescence</kwd><kwd>mesenchymal stromal cells</kwd><kwd>epithelial stem cells</kwd><kwd>oxidative stress</kwd><kwd>regeneration</kwd></kwd-group><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Mouse</kwd></kwd-group><funding-group><award-group id="fund1"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000052</institution-id><institution>NIH Office of the Director</institution></institution-wrap></funding-source><award-id>R01 HL152246</award-id><principal-award-recipient><name><surname>Thannickal</surname><given-names>Victor J</given-names></name></principal-award-recipient></award-group><award-group id="fund2"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000052</institution-id><institution>NIH Office of the Director</institution></institution-wrap></funding-source><award-id>P01 HL114470</award-id><principal-award-recipient><name><surname>Thannickal</surname><given-names>Victor J</given-names></name></principal-award-recipient></award-group><award-group id="fund3"><funding-source><institution-wrap><institution>Veteran Affairs Administration</institution></institution-wrap></funding-source><award-id>I01BX003056</award-id><principal-award-recipient><name><surname>Thannickal</surname><given-names>Victor J</given-names></name></principal-award-recipient></award-group><award-group id="fund4"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000052</institution-id><institution>NIH Office of the Director</institution></institution-wrap></funding-source><award-id>R01 AG046210</award-id><principal-award-recipient><name><surname>Thannickal</surname><given-names>Victor J</given-names></name></principal-award-recipient></award-group><award-group id="fund5"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000052</institution-id><institution>NIH Office of the Director</institution></institution-wrap></funding-source><award-id>R01 HL139617</award-id><principal-award-recipient><name><surname>Zmijewski</surname><given-names>Jaroslaw W</given-names></name><name><surname>Thannickal</surname><given-names>Victor J</given-names></name></principal-award-recipient></award-group><award-group id="fund6"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000052</institution-id><institution>NIH Office of the Director</institution></institution-wrap></funding-source><award-id>P30 CA013148</award-id><principal-award-recipient><name><surname>Mobley</surname><given-names>James A</given-names></name></principal-award-recipient></award-group><award-group id="fund7"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000052</institution-id><institution>NIH Office of the Director</institution></institution-wrap></funding-source><award-id>R01 HL128502</award-id><principal-award-recipient><name><surname>Deshane</surname><given-names>Jessy S</given-names></name></principal-award-recipient></award-group><award-group id="fund8"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000052</institution-id><institution>NIH Office of the Director</institution></institution-wrap></funding-source><award-id>P42 ES027723</award-id><principal-award-recipient><name><surname>Deshane</surname><given-names>Jessy S</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group><custom-meta-group><custom-meta specific-use="meta-only"><meta-name>Author impact statement</meta-name><meta-value>Lung stem cell niche aging is associated with altered bioenergetics, metabolic dysfunction, and senescence of mesenchymal stromal cells that restricts 3D organoid, or alveolosphere formation, potentially accounting for reduced regenerative capacity with aging.</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="s1" sec-type="intro"><title>Introduction</title><p>Substantial progress has been made in our understanding of the biology of aging, and these advances have the potential to improve both healthspan and lifespan, while alleviating the burden of age-related diseases. Self-organization in biological systems is a process by which cells reduce their internal entropy and maintain order within these dynamic, self-renewing systems (<xref ref-type="bibr" rid="bib6">Chatterjee et al., 2017</xref>; <xref ref-type="bibr" rid="bib14">Kiss et al., 2009</xref>). Exhaustion of stem/progenitor cells, cellular senescence, and altered intercellular communication have been proposed as aging hallmarks that increase susceptibility to age-related disorders (<xref ref-type="bibr" rid="bib22">Schultz and Sinclair, 2016</xref>). However, the interactions between these hallmarks and whether cellular bioenergetics associated with cellular senescence may account for age-associated stem cell dysfunction and altered cell-cell communication have not been well defined. In this study, we utilized an organoid model to study stem cell behavior and intercellular communication that may account for age-related phenotypes; through these studies, we identify cellular bioenergetics and redox imbalance as critical drivers of these inter-dependent aging hallmarks.</p></sec><sec id="s2" sec-type="results|discussion"><title>Results and discussion</title><p>The mammalian lung serves an essential role in organismal metabolism, uniquely by serving as the primary organ for systemic exchange of oxygen for carbon dioxide. Regeneration and maintenance of structure-function of the lung are dependent on adult, tissue-resident stem cells that reside in unique niches along the airways (<xref ref-type="bibr" rid="bib3">Basil et al., 2020</xref>; <xref ref-type="bibr" rid="bib11">Hogan et al., 2014</xref>). Type 2 alveolar epithelial cells (AEC2s) serve as facultative stem/progenitor cells in adult mammalian lungs and differentiate into type 1 alveolar epithelial cells (AEC1s) in response to diverse injuries to reconstitute and reestablish the alveolar gas exchange surface (<xref ref-type="bibr" rid="bib2">Barkauskas et al., 2013</xref>). AEC2 regenerative capacity declines with age, resulting in impaired lung injury repair responses, thus increasing susceptibility to various lung diseases (<xref ref-type="bibr" rid="bib21">Schulte et al., 2019</xref>; <xref ref-type="bibr" rid="bib31">Watson et al., 2020</xref>). To further explore the relationship between AECs and lung mesenchymal stromal cells (L-MSCs), we developed an alveolosphere assay system that has been traditionally used to assess AEC2 stemness or regenerative potential (<xref ref-type="bibr" rid="bib2">Barkauskas et al., 2013</xref>). In this assay system, L-MSCs and AEC2s are mixed together in a ratio of 100,000–5000,, respectively, and seeded in Matrigel (<xref ref-type="fig" rid="fig1">Figure 1A</xref>); alveolospheres with a single layer of epithelial cells composed of both AEC2s (surfactant protein C [SFTPC]-positive) and AEC1s (lung type I integral membrane glycoprotein [T1α]-positive) surrounding a hollow sphere typically form 9–12 days following co-culture (<xref ref-type="fig" rid="fig1">Figure 1B and C</xref>). L-MSCs expressing platelet-derived growth factor receptor-α (PDFGRα), with a fewer number expressing α-smooth muscle actin (α-SMA), were found primarily in cells lining the outer edges of alveolospheres (<xref ref-type="fig" rid="fig1">Figure 1D and E</xref>). AEC2s within alveolospheres stained for both the cell proliferation marker, Ki-67, and the double-strand DNA damage repair marker, histone H2A.X, suggesting ongoing AEC2 turnover within these 3D organoids (<xref ref-type="fig" rid="fig1">Figure 1F and G</xref>). This self-organizing behavior of L-MSCs and AEC2s is critically dependent on the presence of both cell types as AEC2s in the absence of AEC2s do not self-organize to form alveolospheres (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1A</xref>). Together, these data support the crosstalk between L-MSCs and AEC2s that permit formation of distinct alveolar organoid-like structures; this intercellular communication may be perturbed during aging accounting for age-associated loss of AEC2 regeneration/maintenance.</p><fig-group><fig id="fig1" position="float"><label>Figure 1.</label><caption><title>Aging lung-mesenchymal stromal cells (L-MSCs) impair self-organization of alveolar epithelial stem cells (AEC2s) and alveolosphere formation.</title><p>(<bold>A</bold>) Alveolosphere assay. AEC2s and L-MSCs were purified from the young (3 months) mice lungs. AEC2s (5000 cells/well) and L-MSCs (100,000 cells/well) were mixed and seeded in Matrigel: MTEC plus media (1:1) and co-cultured in cell-culture inserts in 24-well dishes as shown. Alveolospheres form within 9–12 days of co-culture. (<bold>B</bold>) Alveolosphere whole mounts were immunofluorescently stained with antibody against F-actin (red) for confocal imaging. Image showing maximum intensity projection of an alveolosphere (scale bar = 20 µm). (<bold>C</bold>) Immunofluorescence (IF) staining showing localization of AEC2s (surfactant protein-C [SFTPC], green) and AEC1s (lung type I integral membrane glycoprotein-α [T1-α], red) within the alveolospheres. (<bold>D</bold>) IF staining showing localization of platelet-derived growth factor receptor-α (PDGFR-α, red) expressing alveolar L-MSCs within the alveolospheres. (<bold>E</bold>) Alpha-smooth muscle actin (α-SMA, red) IF staining showing presence of myofibroblasts in the alveolosphere. (<bold>F, G</bold>) Cell proliferation and DNA repair/apoptosis within the alveolospheres were determined by Ki-67 (<bold>F</bold>; red) and histone H2A.X (<bold>G</bold>; red) IF staining, respectively. Nuclei were stained with Hoechst 33,342 (blue; scale bars = 20 µm). (<bold>H</bold>) L-MSCs and AEC2s from young (3 months) and aged mice (24 months) were co-cultured in varied combinations as shown (upper panel); alveolospheres were imaged by brightfield microscopy. Images at low and high magnifications are shown (middle panel, scale bar = 300 µm; lower panel, scale bar = 20 µm). (<bold>I</bold>) Alveolospheres in each well were counted (n = 4 mice); box and whiskers plot showing median alveolosphere count in each group (p<italic>&gt;</italic>0.05; ANOVA; Tukey’s pairwise comparison test). (<bold>J</bold>) Alveolosphere sizes (volumes) were determined for each of the co-culture groups using ImageJ v1.47 software. Nested scatterplot showing mean ± SEM of all the alveolospheres counted in each well for each group (n = 4 mice; ***p<italic>&lt;</italic>0.001, young AEC2s:young L-MSCs vs. young AEC2s:aged L-MSCs; aged AEC2s:young L-MSCs vs. aged AEC2s:aged L-MSCs; ****p<italic>&lt;</italic>0.0001, young AEC2s:young L-MSCs vs. aged AEC2s:aged L-MSCs; ANOVA followed by Tukey’s pairwise comparison test).</p><p><supplementary-material id="fig1sdata1"><label>Figure 1—source data 1.</label><caption><title>Alveolosphere formation with varying combinations of L-MSCs and AEC2s.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-68049-fig1-data1-v1.xlsx"/></supplementary-material></p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-68049-fig1-v1.tif"/></fig><fig id="fig1s1" position="float" specific-use="child-fig"><label>Figure 1—figure supplement 1.</label><caption><title>Measurements of alveolosphere size and number.</title><p>(<bold>A</bold>) Alveolosphere assay. Type 2 alveolar epithelial cells (AEC2s) do not form alveolospheres in the absence of lung mesenchymal stromal cells (L-MSCs). (<bold>B</bold>) Aging L-MSCs impair self-organization of AEC2s and alveolosphere formation. L-MSCs and AEC2s were isolated from young (3 months) and aged (24 months) mice and co-cultured as described. Varied combinations of AEC2s and L-MSCs from lungs of mice were studied (scale bar = 300 µm). Alveolospheres were imaged by brightfield microscopy after 12 days of co-culture. Experimental replicates (<xref ref-type="fig" rid="fig1">Figure 1H</xref>) are shown here.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-68049-fig1-figsupp1-v1.tif"/></fig></fig-group><p>To determine the effect of age on cellular self-organization and alveolosphere formation, L-MSCs and AEC2s were isolated from the lungs of young (2–3 months) and aged (22–24 months) mice and seeded in various combinations (<xref ref-type="fig" rid="fig1">Figure 1H</xref>, upper panel). L-MSCs and AEC2s from young mice generated normal alveolospheres, whereas L-MSCs and AEC2s from the lungs of aged mice showed impaired self-organization with condensed, poorly formed organoids. Interestingly, combining aged AEC2s with young L-MSCs resulted in relatively normal-appearing alveolospheres, while the reverse combination (young AEC2s and old L-MSCs) did not (<xref ref-type="fig" rid="fig1">Figure 1H</xref>, middle and lower panels; <xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1B</xref>). Quantitative analyses revealed that, while the number of alveolospheres formed was not significantly different between groups (<xref ref-type="fig" rid="fig1">Figure 1I</xref>), the size of alveolospheres was critically dependent on the age of L-MSCs, and not that of AEC2s (<xref ref-type="fig" rid="fig1">Figure 1J</xref>). These findings indicate that secreted factor(s) from young L-MSCs are capable of supporting the self-organizing behavior of alveolospheres, while aged L-MSCs do not.</p><p>Cellular senescence accumulates in tissues with advancing age (<xref ref-type="bibr" rid="bib15">Krishnamurthy et al., 2004</xref>) and has been proposed as a key driver of aging and aging-related disease phenotypes (<xref ref-type="bibr" rid="bib1">Baker et al., 2016</xref>; <xref ref-type="bibr" rid="bib13">Kennedy et al., 2014</xref>). Based on our observation that aged L-MSCs were incapable of supporting alveolosphere formation, we explored whether the emergence of cellular senescence may account for this finding. First, we confirmed the senescent features of L-MSCs from aged mice in monolayer 2D cell culture (<xref ref-type="fig" rid="fig2">Figure 2A</xref>, <xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1</xref>) and in 3D alveolospheres (<xref ref-type="fig" rid="fig2">Figure 2B</xref>) by staining for β-galactosidase (β-gal) (<xref ref-type="bibr" rid="bib7">Dimri et al., 1995</xref>) and lipofuscin (<xref ref-type="bibr" rid="bib9">Georgakopoulou et al., 2013</xref>), respectively. To characterize secreted factors that may account for the age-associated dysregulation of cell-cell communication, we first measured cytokines/growth factors secreted from both young and aged L-MSCs using antibody arrays (<xref ref-type="fig" rid="fig2">Figure 2C</xref>). A number of cytokines that have been associated with the senescence-associated secretory phenotype (SASP) were found to be released at higher levels by aged L-MSCs, including IL-6, CCL12/MCP-5, CCL11/Eotaxin, and WISP-1/CCN4; in contrast, IGFBP1 was the only secreted protein that was statistically more elevated in young L-MSCs in this cytokine array (<xref ref-type="fig" rid="fig2">Figure 2D and E</xref>).</p><fig-group><fig id="fig2" position="float"><label>Figure 2.</label><caption><title>Aged lung mesenchymal stromal cells (L-MSCs) show redox imbalance and acquire senescence-associated secretory phenotype.</title><p>(<bold>A</bold>) β-Galactosidase activity assay. Young and aged L-MSCs were plated in 6-well dishes at a density of 150,000 L-MSCs/well. L-MSCs were allowed to attach overnight and stained for β-galactosidase activity (scale bar = 50 µm). (<bold>B</bold>) Lipofuscin granules were detected in the alveolosphere paraffin sections by Sudan Black B staining. Sections were also stained with nuclear fast red for contrast (scale bar = 20 µm). (<bold>C</bold>) Cytokine array. 150,000 young and aged L-MSCs were plated in each well of a 6-well culture dish and grown overnight. Cells were washed with PBS and cultured for 24 hr in serum-free media (SFM; 1.5 ml/well). The culture media were pooled for each cell type and centrifuged to remove any cell and debris. 1 ml of supernatant was applied to antibody array, dotted with antibodies against 111 mouse cytokines and growth factors in duplicates. (<bold>D</bold>) Antibody array showing comparative expression of cytokines and growth factors in the culture media obtained from young and aged L-MSCs. Cytokines and growth factors showing significant difference are numbered and circled. (<bold>E</bold>) Signal intensity was determined for each dot using Image Quant array analysis software; mean signal intensity was calculated for each cytokine, and plotted. Twelve proteins with statistically significant difference (n = 6 samples from three mice; p<italic>&lt;</italic>0.05; unpaired t-test) between the young and aged L-MSCs are shown. Data presented here include pooled data from three independent experiments. (<bold>F</bold>) Proteomics/mass spectrometry analysis. Cell culture media were collected from young and aged L-MSCs (10<sup>6</sup> cells) after 24 hr of growth in SFM in 10 cm dishes and subjected to proteomics analysis by liquid chromatography-mass spectrometry (LCMS). (<bold>G</bold>) A three-dimensional principal component analysis (PCA) plot showing replicated samples (young and aged) are relatively similar in their protein expression profiles and grouped together. (<bold>H</bold>) Heat map showing comparative expression of highly secreted proteins in the culture media between young and aged L-MSCs (n = 4 mice). (<bold>I</bold>) The top 36 proteins showing statistically significant difference (n = 4 mice; p<italic>&lt;</italic>0.05; unpaired t-test) between the young and aged L-MSC secretome are plotted. Gene ontology, processes, and network analyses were performed on the mass spectrometry data, and results are provided in <xref ref-type="supplementary-material" rid="supp1">Supplementary file 1</xref>.</p><p><supplementary-material id="fig2sdata1"><label>Figure 2—source data 1.</label><caption><title>Cytokine array and mass spectrometry data comparing young and aged L-MSCs.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-68049-fig2-data1-v1.xlsx"/></supplementary-material></p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-68049-fig2-v1.tif"/></fig><fig id="fig2s1" position="float" specific-use="child-fig"><label>Figure 2—figure supplement 1.</label><caption><title>Aged lung mesenchymal stromal cells (L-MSCs) show features of senescence.</title><p>β-Galactosidase staining was performed to determine senescence of aged L-MSCs (vs. young) L-MSCs. Low-magnification images are shown here (scale bar = 300 µm).</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-68049-fig2-figsupp1-v1.tif"/></fig></fig-group><p>In addition to predefined cytokine array analyses, we employed an unbiased approach to identification of secreted proteins from young and aged L-MSCs by mass spectrometry-based discovery proteomics (<xref ref-type="fig" rid="fig2">Figure 2F</xref>). After adjustments for false discovery rates, 503 high-confidence proteins were identified; of these, 235 proteins were found to have non-zero quantifiable values in at least three of four experimental repeats per group for subsequent statistical analysis. The 36 proteins that passed both a single pairwise statistical test (p<italic>&lt;</italic>0.05) in addition to a fold change of ±1.5 (<xref ref-type="supplementary-material" rid="supp1">Supplementary file 1A</xref>) were subjected to principal component analysis (PCA) (<xref ref-type="fig" rid="fig2">Figure 2G</xref>) and heat map analysis (<xref ref-type="fig" rid="fig2">Figure 2H</xref>; quantitation of heat map proteins, <xref ref-type="fig" rid="fig2">Figure 2I</xref>). Gene ontology localization analyses revealed enrichment in secreted proteins, including extracellular vesicles and extracellular matrix (<xref ref-type="supplementary-material" rid="supp1">Supplementary file 1B</xref>); interestingly, gene ontology processes analysis indicated the top cellular processes as negative regulation of reactive oxygen species metabolic process and extracellular matrix/structure organization (<xref ref-type="supplementary-material" rid="supp1">Supplementary file 1C</xref>). Enrichment by top toxic pathologies revealed proteins associated with lung fibrosis (<xref ref-type="supplementary-material" rid="supp1">Supplementary file 1D</xref>), a disease associated with aging (<xref ref-type="bibr" rid="bib29">Thannickal et al., 2014</xref>). Network analysis revealed upregulation of pathways associated with the canonical WNT-signaling pathway and cell cycle regulation (<xref ref-type="supplementary-material" rid="supp1">Supplementary file 1E</xref>). Together, these findings suggest that aged L-MSCs are characterized by cellular senescence associated with SASP factors, oxidative stress, and alterations in regenerative pathways that may account for impaired alveolosphere formation.</p><p>Altered cellular metabolism has been linked to both senescence and aging (<xref ref-type="bibr" rid="bib18">López-Otín et al., 2016</xref>; <xref ref-type="bibr" rid="bib8">Finkel, 2015</xref>; <xref ref-type="bibr" rid="bib25">Sun et al., 2016</xref>). To compare the energy state between young and aged lung L-MSCs, rates of mitochondrial respiration and glycolysis were analyzed by Seahorse XF Analyzer. Real-time oxygen consumption rates (OCR) and extracellular acidification rates (ECAR) were significantly higher in aged L-MSCs as compared to young L-MSCs (<xref ref-type="fig" rid="fig3">Figure 3A and B</xref>). Aged L-MSCs showed significantly higher basal, maximal, ATP-linked, proton leak, and non-mitochondrial respiration when compared to young L-MSCs with no change in reserve capacity (<xref ref-type="fig" rid="fig3">Figure 3C-H</xref>). Higher non-mitochondrial OCRs in aged L-MSCs suggest potential activation of oxygen-metabolizing NADPH oxidases in aged L-MSCs. An energy map profile of the OCR and ECAR data indicated a higher basal rate of both mitochondrial respiration and glycolysis (<xref ref-type="fig" rid="fig3">Figure 3I</xref>), suggesting that aged L-MSCs are under a basal state of higher metabolic demand. This higher energy demand under conditions of equivalent nutrient supply was associated with reduced levels of ATP/ADP under steady-state basal conditions (<xref ref-type="fig" rid="fig3">Figure 3J</xref>). Measurement of ECAR indicated that, despite similar basal ECAR, higher rates of maximal and non-glycolysis related ECAR were observed in aged L-MSCs. (<xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1</xref>). Together, these data indicate that senescence of L-MSCs is characterized by higher baseline metabolic demand with reduced bioenergetic efficiency.</p><fig-group><fig id="fig3" position="float"><label>Figure 3.</label><caption><title>Senescent lung mesenchymal stromal cells (L-MSCs) demonstrate altered bioenergetics.</title><p>Young and aged mouse L-MSCs were grown in complete Dulbecco's Modified Eagle Medium (DMEM) for 24 hr. 25,000 cells were seeded in Seahorse XF-24 cell culture microplates. The cells were treated sequentially with mitochondrial inhibitors: oligomycin (Oligo), carbonyl cyanide 4-(trifluoromethoxy) phenylhydrazone (FCCP), antimycin (AA), and glycolytic inhibitor: 2-deoxy-d-glucose (2-DG). (<bold>A</bold>) Real-time oxygen consumption rates (OCRs) and (<bold>B</bold>) real-time extracellular acidification rates (ECARs) between the young and aged L-MSCs were compared. (<bold>C–H</bold>) Basal, ATP-linked, proton leak, maximal, reserve capacity, and non-mitochondria-related OCRs were calculated and plotted (n = 8 mice; 10 technical replicates of each averaged; *p<italic>&lt;</italic>0.05, **p<italic>&lt;</italic>0.01; unpaired t-test; vs. young L-MSCs). (<bold>I</bold>) An energy map was generated from the OCR and ECAR data (above) showing higher basal rate of both mitochondrial respiration and glycolysis in aged L-MSCs. (<bold>J</bold>) ATP/ADP ratio. Young and aged L-MSCs (10,000 cells) were plated in 96-well flat-bottomed dish and allowed to attach. Cells were treated for 5 min with nucleotide-releasing buffer. Relative ATP and ADP levels were measured from luminescent conversion of ATP-dependent luciferin by the luciferase enzyme. ATP/ADP ratio was calculated and plotted. Graph showing comparative ATP/ADP ratio between young and aged L-MSCs (n = 5 technical replicates; **p<italic>&lt;</italic>0.01; unpaired t-test; vs. young L-MSCs).</p><p><supplementary-material id="fig3sdata1"><label>Figure 3—source data 1.</label><caption><title>Bioenergetics of senescent L-MSCs.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-68049-fig3-data1-v1.xlsx"/></supplementary-material></p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-68049-fig3-v1.tif"/></fig><fig id="fig3s1" position="float" specific-use="child-fig"><label>Figure 3—figure supplement 1.</label><caption><title>Aged lung mesenchymal stromal cells (L-MSCs) show features of senescence and altered bioenergetics.</title><p>Basal, oligo-sensitive, non-glycolysis-related, and maximal extracellular acidification rates (ECARs) are shown here (n = 8 mice; 10 technical replicates of each averaged; <italic>**</italic>p<italic>&lt;</italic>0.01; ns: not significant).</p><p><supplementary-material id="fig3s1sdata1"><label>Figure 3—figure supplement 1—source data 1.</label><caption><title>ECAR measurements in young and aged L-MSCs.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-68049-fig3-figsupp1-data1-v1.xlsx"/></supplementary-material></p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-68049-fig3-figsupp1-v1.tif"/></fig></fig-group><p>Hydrogen peroxide (H<sub>2</sub>O<sub>2</sub>) has emerged as critical regulator of redox signaling and oxidative stress (<xref ref-type="bibr" rid="bib23">Sies, 2017</xref>). Replication-induced senescence of human lung fibroblasts results in higher rates of extracellular H<sub>2</sub>O<sub>2</sub> release in association with increased expression of NADPH oxidase 4 (Nox4) (<xref ref-type="bibr" rid="bib20">Sanders et al., 2015</xref>), a gene that is inducible by the pro-senescent/pro-fibrotic mediator, transforming growth factor-β1 (TGF-β1) (<xref ref-type="bibr" rid="bib10">Hecker et al., 2009</xref>). We explored whether L-MSCs isolated from naturally aged mice are associated with higher Nox4-dependent H<sub>2</sub>O<sub>2</sub> secretion; in comparison to young (3 months old) L-MSCs, aged (22–24 months old), L-MSCs released higher baseline levels of H<sub>2</sub>O<sub>2</sub>, an effect that was further stimulated by exogenous stimulation with TGF-β1 (<xref ref-type="fig" rid="fig4">Figure 4A</xref>). This age-dependent, pro-oxidant phenotype of L-MSCs was markedly reduced in aged mice heterozygous for Nox4 (<italic>Nox4<sup>-/+</sup></italic>; <xref ref-type="fig" rid="fig4">Figure 4B and C</xref>), implicating Nox4 as a critical mediator of both basal and TGF-β1-induced H<sub>2</sub>O<sub>2</sub> release. Although it is difficult to replicate the tonic, continuous release of H<sub>2</sub>O<sub>2</sub> from a constitutive enzymatic source such as Nox4 in metabolically active cells, we tested the effect of a bolus addition of H<sub>2</sub>O<sub>2</sub> (1 µM) to organoid culture comprising young AEC2s and young L-MSCs; this resulted in a decrease in the size of alveolospheres, without significantly affecting the numbers of alveolospheres formed (<xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1A–C</xref>).</p><fig-group><fig id="fig4" position="float"><label>Figure 4.</label><caption><title>Nox4 deficiency in aged lung mesenchymal stromal cell (L-MSC) improves bioenergetics and restores type 2 alveolar epithelial cell (AEC2) self-organization.</title><p>(<bold>A</bold>) Hydrogen peroxide (H<sub>2</sub>O<sub>2</sub>)-release assay. Young and aged L-MSCs were grown in very low serum (1%) containing media for 24 hr and treated with either transforming growth factor-β1 (TGF-β1) or vehicle for 16 hr, and real-time H<sub>2</sub>O<sub>2</sub> release was determined. Here, bar graph showing comparative H<sub>2</sub>O<sub>2</sub> release between young and aged L-MSCs with or without TGF-β1 treatment (n = 6 technical replicates; ****p<italic>&lt;</italic>0.0001; unpaired t-test). (<bold>B</bold>) RT-PCR analysis. Total RNA was isolated from aged and aged <italic>Nox4<sup>-/+</sup></italic> L-MSCs, and subjected to real-time PCR analysis for Nox4 mRNA expression. Data were normalized to β-actin and represented graphically as fold change compared to aged L-MSCs (n = 3 mice; three technical replicates of each averaged; **p<italic>&lt;</italic>0.01; unpaired t-test). (<bold>C</bold>) Data showing comparative H<sub>2</sub>O<sub>2</sub> release between aged and aged <italic>Nox4<sup>-/+</sup></italic> L-MSCs at baseline and after TGF-β1 treatment (n = 6 technical replicates; ****p<italic>&lt;</italic>0.0001; unpaired t-test). (<bold>D</bold>) Bar graph showing comparative ATP/ADP ratio between young, aged, and aged <italic>Nox4<sup>-/+</sup></italic> L-MSCs (n = 5 technical replicates; **p<italic>&lt;</italic>0.01, *p&lt;0.05). (<bold>E, F</bold>) Targeted metabolomics. Relative levels of tricarboxylic acid cycle metabolites were determined and compared between young, aged, and aged <italic>Nox4<sup>-/+</sup></italic> L-MSCs. Concentrations of malate (<bold>E</bold>) and citrate (<bold>F</bold>) are shown here (n = 3 technical replicates; *p&lt;0.05; **p&lt;0.01). (<bold>G, H</bold>) Real-time oxygen consumption rates (OCRs) between the young, aged, and aged <italic>Nox4<sup>-/+</sup></italic> L-MSCs were compared. Basal, ATP-linked, proton leak, maximal, reserve capacity, and non-mitochondria-related OCRs were calculated and plotted (n = 4 mice/group; 10 technical replicates of each averaged; <italic>*</italic>p&lt;0.05, **p&lt;0.01; ***p&lt;0.001). (<bold>I</bold>) Alveolosphere assay. Young, aged, and aged <italic>Nox4<sup>-/+</sup></italic> L-MSCs were co-cultured with young AEC2s in a ratio described earlier (upper panel). The alveolospheres were imaged by brightfield microscopy after 12 days of co-culture, and comparative outcomes are shown here in low (middle panel; scale bar = 300 µm) and higher magnifications (lower panel; scale bar = 20 µm). (<bold>J</bold>) Alveolospheres in each well were counted (mean ± SEM; n = 3 mice; **p<italic>&lt;</italic>0.01; ***p<italic>&lt;</italic>0.001). (<bold>K</bold>) Alveolosphere sizes (volumes) were determined for each of the three co-culture groups. Nested scatterplot showing mean ± SEM of all the alveolospheres counted in each well for each group (n = 3 mice; **p&lt;0.01, ***p&lt;0.001, ****p&lt;0.0001). (<bold>D–K</bold>) Statistical analysis: ANOVA followed by Tukey’s pairwise comparison test. (<bold>L</bold>) Schematic summarizing the important findings from this study.</p><p><supplementary-material id="fig4sdata1"><label>Figure 4—source data 1.</label><caption><title>Functional characteristics of wild type and Nox4-deficient aged L-MSCs.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-68049-fig4-data1-v1.xlsx"/></supplementary-material></p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-68049-fig4-v1.tif"/></fig><fig id="fig4s1" position="float" specific-use="child-fig"><label>Figure 4—figure supplement 1.</label><caption><title>Role of Nox4 in senescent L-MSCs and alveolosphere formation.</title><p>(<bold>A</bold>) Young lung mesenchymal stromal cells (L-MSCs) were co-cultured with young type 2 alveolar epithelial cells (AEC2s) in the presence of H<sub>2</sub>O<sub>2</sub>. The alveolospheres were imaged by brightfield microscopy after 12 days of co-culture, and comparative outcomes are shown here in low magnification (scale bar = 500 µm) (<bold>B</bold>) Alveolospheres in each well were counted (mean ± SEM; n = 4 mice/group). (<bold>C</bold>) Alveolosphere sizes (volumes) were determined for each of the two co-culture groups. Nested scatterplot showing mean ± SEM (cutoff 200 µm diameter shown) of all the alveolospheres counted in each well for each group (n = 4 mice/group; *p<italic>&lt;</italic>0.05; unpaired t-test). Targeted metabolomics: concentrations of (<bold>D</bold>) fumarate, (<bold>E</bold>) α-ketoglutarate, (<bold>F</bold>) succinate, and (<bold>G</bold>) pyruvate in young, aged, and Nox4-deficient L-MSCs were also determined and plotted (n = 3 technical replicates; p<italic>&gt;</italic>0.05; ns: not significant; ANOVA and Tukey’s pairwise comparison test). (<bold>H</bold>) β-Galactosidase activity assay. Young, aged, and aged <italic>Nox4<sup>-/+</sup></italic> L-MSCs were compared for β-galactosidase activity (scale bars = 200 µm [upper panel]; 50 µm [lower panel]). (<bold>I</bold>) Antibody-based protein array comparing cytokines and growth factors released from aged, and aged <italic>Nox4<sup>-/+</sup></italic> L-MSCs. Twenty-three proteins that were found to have a statistically significant difference between the young and aged L-MSCs are shown (n = 8–12 samples from 3 to 4 mice/group; p&lt;0.05; unpaired t-test). (<bold>J</bold>) Nox4-deficiency in aged L-MSCs improves bioenergetics and restores AEC2 self-organization. L-MScs were isolated from young, aged, and <italic>Nox4<sup>-/+</sup></italic> aged mice and co-cultured with young AEC2s as described earlier. Varied combinations of AEC2s and L-MSCs from lungs of mice were studied. Alveolospheres were imaged by brightfield microscopy after 12 days of co-culture. Experimental replicates shown in <xref ref-type="fig" rid="fig4">Figure 4I</xref> (middle panel) are shown here. (<bold>K</bold>) Young AEC2s were co-cultured with aged L-MSCs in the presence of a Nox4 inhibitor (GKT137831; 10 µM). The alveolospheres were imaged, and comparative outcomes are shown here (scale bar = 500 µm). (<bold>L</bold>) Alveolospheres in each well were counted (mean ± SEM; n = 4 mice). (<bold>M</bold>) Alveolosphere sizes (volumes) were determined for each of the two co-culture groups. Nested scatterplot showing mean ± SEM (cutoff 100 µm diameter shown) of all the alveolospheres counted in each well for each group (n = 4 mice/group; ns: nonsignificant; unpaired t-test). (<bold>N</bold>) Aged AEC2s were co-cultured with either aged L-MSCs or aged <italic>Nox4<sup>-/+</sup></italic> L-MSCs. The alveolospheres were imaged, and comparative outcomes are shown here (scale bar = 500 µm). (<bold>O</bold>) Alveolospheres in each well were counted (mean ± SEM; n = 4 mice/group). (<bold>P</bold>) Alveolosphere sizes (volumes) were determined for each of the two co-culture groups. Nested scatterplot showing mean ± SEM (cutoff 200 µm diameter shown) of all the alveolospheres counted in each well for each group (n = 4 mice; ns; unpaired t-test). (<bold>A</bold>,<bold> K</bold>, and <bold>N</bold>) were co-cultured in a single experiment. Data in (<bold>C</bold>, <bold>M</bold>, and <bold>P</bold>) were natural log transformed before t-test.</p><p><supplementary-material id="fig4s1sdata1"><label>Figure 4—figure supplement 1—source data 1.</label><caption><title>Characterization of metabolism, SASP profile, and alveolosphere formation in Nox4-deficient L-MSCs.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-68049-fig4-figsupp1-data1-v1.xlsx"/></supplementary-material></p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-68049-fig4-figsupp1-v1.tif"/></fig></fig-group><p>Recent studies implicate Nox4 in metabolic reprogramming (<xref ref-type="bibr" rid="bib4">Bernard et al., 2017</xref>), although the effects of Nox4 on age-related metabolic dysfunction are unclear. The reduced levels of ATP/ADP in aged L-MSCs were partially rescued in age-matched <italic>Nox4<sup>-/+</sup></italic> L-MSCs (<xref ref-type="fig" rid="fig4">Figure 4D</xref>), implicating a role for Nox4 in the reduced bioenergetic efficiency associated with aging. The steady-state levels of the tricarboxylic acid (TCA) cycle metabolites, malate and citrate, were reduced in wild-type aged L-MSCs; these levels recovered to levels similar to young L-MSCs in <italic>Nox4<sup>-/+</sup></italic> L-MSCs, although only malate achieved statistical significance (<xref ref-type="fig" rid="fig4">Figure 4E and F</xref>). Levels of other TCA metabolites that were not significantly altered with aging in L-MSCs were not affected by a deficiency in Nox4 (<xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1D-G</xref>). β-gal activity was found to be significantly lower in Nox4-deficient aged L-MSCs as compared to wild-type aged L-MSCs (<xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1H</xref>). In addition to metabolic dysfunction, an important feature of senescence reprogramming is the activation of a SASP program. We determined whether Nox4 modulates the release of cytokines/growth factors by aged L-MSCs. Protein (antibody-based) arrays showed significant downregulation of SASP-associated cytokines in aged <italic>Nox4<sup>-/+</sup></italic> L-MSCs vs. aged L-MSCs (<xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1I</xref>). We were unable to identify a group of cytokines (except for coagulation factor III) that were specifically identified in the dataset comparing young vs. aged L-MSCs based on the antibody-based cytokine array method. Further studies with an unbiased approach such as that employed by mass spectrometric analyses (<xref ref-type="fig" rid="fig2">Figure 2I</xref>) will be required for more in-depth analyses of Nox4 regulated SASP cytokines/growth factors. Interestingly, Nox4 haploinsufficiency in aged L-MSCs resulted in significant downregulation of OCR as compared to aged L-MSCs (<xref ref-type="fig" rid="fig4">Figure 4G</xref>). <italic>Nox4<sup>-/+</sup></italic> aged L-MSCs showed significantly lower basal, ATP-linked, proton leak, and maximal respiration compared to wild-type aged L-MSCs. Non-mitochondrial respiration was also lower in aged <italic>Nox4<sup>-/+</sup></italic> L-MSCs, although this did not achieve statistical significance (<xref ref-type="fig" rid="fig4">Figure 4H</xref>). Together, these studies indicate that Nox4 contributes to metabolic dysfunction, bioenergetic inefficiency, and SASP programming in L-MSC aging.</p><p>Based on the observations that Nox4 alters cellular bioenergetics of L-MSCs, we examined the effects of Nox4 on regulating the self-organizing potential of alveolospheres. The aberrant formation of alveolospheres when young AEC2s were cultured with aged L-MSCs were rescued when replaced with age-matched <italic>Nox4<sup>-/+</sup></italic> L-MSCs (<xref ref-type="fig" rid="fig4">Figure 4I</xref>; <xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1J</xref>); quantitation of both alveolospheres counts (<xref ref-type="fig" rid="fig4">Figure 4J</xref>) and alveolosphere size (<xref ref-type="fig" rid="fig4">Figure 4K</xref>) was significantly enhanced when these assays were conducted with Nox4-deficient L-MSCs. We were also unable to detect significant changes in alveolosphere formation when the Nox4 inhibitor, GKT137831 (10 µM), was added to an organoid culture system of young AEC2s and aged L-MSCs (<xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1K-M</xref>); however, it is difficult to ascertain whether this intervention effectively inhibited Nox4 activity in this organoid model. While the phenotype of impaired alveolosphere formation in young AECs and aged L-MSCs was reversed by haploinsufficiency of Nox4 in L-MSCs (<xref ref-type="fig" rid="fig4">Figure 4I–K</xref>), this was not sufficient to completely reverse the phenotype in aged AEC2s (<xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1N-P</xref>). This finding, along with the observation that wild-type young L-MSCs are sufficient to reverse the aged AEC2 phenotype (<xref ref-type="fig" rid="fig1">Figure 1H</xref>), suggests that in addition to reduced expression of Nox4 in aged L-MSCs, the young mesenchyme may support niche function and recovery of alveolosphere formation of aged AEC2s through Nox4-independent mechanisms. Thus, an aging alveolar stem cell niche may involve both a gain of ‘pro-senescent factors’ (Nox4) and loss of ‘rejuvenation factors’ by the mesenchyme; the identification of the latter will require further study. Together, our studies support a critical role for Nox4-dependent oxidative stress, senescence, and bioenergetic insufficiency in restricting the capacity for cellular self-organization in a 3D organoid model of aging and stem/progenitor cell function (<xref ref-type="fig" rid="fig4">Figure 4L</xref>).</p><p>A fundamental difference between non-living matter and life forms on our planet is the ability to extract energy from the environment, primarily through oxidation of carbon-based fuels. Thus, the second law of thermodynamics that governs both living and non-living matter does not strictly apply to living organisms capable of self-renewal through the continuous and dynamic exchange of energy (from exogenous nutrients) and mass (biosynthetic and degradative processes in respiring tissues/organs). It follows then that, when this capacity for energy-dependent self-renewal is diminished, the law of entropic degeneration will be operative in living organisms. Aging is associated with derangements in metabolism that influences, and may in fact control, many of the well-recognized hallmarks of aging, including cellular senescence (<xref ref-type="bibr" rid="bib18">López-Otín et al., 2016</xref>; <xref ref-type="bibr" rid="bib17">López-Otín et al., 2013</xref>). The inter-relatedness of metabolism with these traditional aging hallmarks is difficult to untangle due to complexities of studies in living organisms and the relative simplicity of 2D cell culture models.</p><p>Organoids offer the opportunity to study complex living phenomena such as emergent properties and self-organization in biological systems while at the same time allowing for reductionist approaches that provide mechanistic understanding of these complex processes. Using a combination of methods that included a 3D organoid model, biochemical approaches, proteomics, and gene targeting, we demonstrate a critical role for the oxygen metabolizing enzyme, Nox4, in regulating cellular bioenergetics and senescence that limits stem cell function. Consistent with contemporary theories on aging, Nox4 may function as an antagonistically pleiotropic gene and contribute a number of age-related degenerative disorders, including fibrotic diseases (<xref ref-type="bibr" rid="bib28">Thannickal, 2010</xref>; <xref ref-type="bibr" rid="bib16">Lambeth, 2007</xref>). Interestingly, proteomic analyses of proteins secreted by aged L-MSCs in the current study suggested alterations in cellular redox/oxidative stress (from gene ontology analysis) and lung fibrosis (as a ‘toxic pathology’). These findings, as well as candidate SASP factors, highlight the emerging importance of intercellular communication and stem cell exhaustion as important hallmarks of aging (<xref ref-type="bibr" rid="bib17">López-Otín et al., 2013</xref>).</p><p>Regenerative mechanisms in adult, mammalian organisms primarily rely on the activation and differentiation of tissue/organ-resident stem cells (<xref ref-type="bibr" rid="bib11">Hogan et al., 2014</xref>). Homeostatic maintenance of these stem cells requires a tightly regulated niche that includes other supporting cell types, in particular stromal cells (<xref ref-type="bibr" rid="bib3">Basil et al., 2020</xref>). An important finding from our studies is the observation that L-MSC aging, relative to AEC aging, largely accounts for the age-related inability to form alveolospheres. Thus, aging of the stem cell niche may be as important, and perhaps more decisive, in promoting certain age-related pathologies. Therapeutic targeting of metabolic aging within the stem cell niche, specifically that of lung-resident fibroblasts/myofibroblasts, may offer a more effective and viable strategy for age-related degenerative disorders such as tissue/organ fibrosis.</p></sec><sec id="s3" sec-type="materials|methods"><title>Materials and methods</title><sec id="s3-1"><title>Key resources</title><p>All reagents, antibodies, assay kits, and mice used in this study are listed in Appendix 1—key resources table.</p><p>All animal protocols were approved by the Institutional Animal Care and Use Committees (IACUC) at the University of Alabama at Birmingham. The mice were acclimatized in the animal facility at least for a week before experiments. Male mice were used in this study for their greater susceptibility to age-related diseases.</p></sec><sec id="s3-2"><title>Cell culture</title><p>Mouse lung L-MSCs were isolated and propagated following protocol developed in our laboratory (<xref ref-type="bibr" rid="bib30">Vittal et al., 2005</xref>). L-MSCs were isolated by collagenase digestion of the lungs and anchorage-dependent ex vivo growth on plastic culture dishes in Dulbecco's Modified Eagle Medium (DMEM) supplemented with 10% fetal bovine serum, 4 mM L-glutamine, 4.5 g/L glucose, 100 U/ml penicillin, 100 μg/ml streptomycin, and 1.25 μg/ml amphotericin B (Fungizone), in a humified chamber at 37°C in 5% CO<sub>2</sub>, 95% air. AEC2s were isolated and purified from the young and aged mice lungs via enzymatic digestion (Dispase II), cell-specific antibody labeling (biotinylated Ter-119, CD104, CD16/32, CD45, CD31), and magnetic separation (Anti-Biotin MicroBeads) following published protocols (<xref ref-type="bibr" rid="bib24">Sinha and Lowell, 2016</xref>) and used immediately. AEC2 purity was determined by fluorescent detection of EpCam<sup>+</sup>/SFTPC<sup>+</sup>/CD45<sup>-</sup>/CD31<sup>-</sup> cell population using flow cytometry (<xref ref-type="bibr" rid="bib24">Sinha and Lowell, 2016</xref>; <xref ref-type="bibr" rid="bib5">Bertoncello and Mcqualter, 2011</xref>). L-MSCs and AEC2s were seeded in Matrigel mixed with MTEC/plus media (<xref ref-type="bibr" rid="bib32">You et al., 2002</xref>) (1:1) in cell culture inserts (24-well format, 0.4 µm pore size), and co-cultured in MTEC/Plus media as shown in <xref ref-type="fig" rid="fig1">Figure 1A</xref>.</p></sec><sec id="s3-3"><title>Immunofluorescence staining</title><p>Matrigel containing alveolospheres were fixed in 4% paraformaldehyde, embedded in HistoGel, dehydrated, and paraffin embedded using standard protocol. 5-µm-thick sections were cut and mounted on glass slides and immunostained for mouse SFTPC, T1-α, PDGFRα, α-SMA, Ki-67, and histone 2A.X (H2A.X). Briefly, alveolosphere sections were deparaffinized in xylene and hydrated through ethanol series and water. Antigen retrieval was performed using citrate buffer at pH 6.0 in a 95°C water bath. Tissue sections were blocked using 5% normal goat or donkey serum and were then incubated in primary antibodies overnight at 4°C. Appropriate IgG isotype controls were also used to determine specificity of staining. Secondary detection was performed using anti-mouse Alexa Fluor 594/488-tagged secondary antibodies. Nuclei were counterstained with Hoechst 33342 dye for immunofluorescence detection. The stained alveolosphere sections were mounted in Vectashield and viewed and imaged in a Keyence BZ-X710 inverted microscope with brightfield as well as fluorescent imaging capability.</p></sec><sec id="s3-4"><title>Histochemical staining</title><p>β-Galactosidase staining was performed on young and aged L-MSCs in culture, according to instructions provided in the Senescence Detection Kit (Abcam). Lipofuscin staining was performed on paraffin sections of alveolospheres following published protocol (<xref ref-type="bibr" rid="bib9">Georgakopoulou et al., 2013</xref>).</p></sec><sec id="s3-5"><title>Cytokine array</title><p>Cytokine array was carried out in the young and aged L-MSC culture media using Proteome Profiler Mouse XL Cytokine Array kit (R&amp;D Systems) as per the manufacturer’s instructions.</p></sec><sec id="s3-6"><title>Proteomics/mass spectrometry analysis</title><p>Proteomics analysis was carried out following established protocols (<xref ref-type="bibr" rid="bib19">Ludwig et al., 2016</xref>) with minor changes. Briefly, 5 ml of each cell culture media specimen were concentrated using Amicon Ultra 4 ml, 3 kDa molecular weight cutoff filters (Millipore) and protein concentrations were determined using Pierce BCA Protein Assay Kit. Proteins (10 µg) per sample were reduced with DTT and denatured at 70°C for 10 min prior to loading onto Novex NuPAGE 10% Bis-Tris Protein gels (Invitrogen, Cat. # NP0315BOX). The gels were stained overnight with Novex Colloidal Blue Staining kit (Invitrogen, Cat. # LC6025). Following destaining, each lane was cut into 3 MW fractions and equilibrated in 100 mM ammonium bicarbonate (AmBc), each gel plug was then digested overnight with Trypsin Gold, Mass Spectrometry Grade (Promega, Cat. # V5280) following the manufacturer’s instruction. Peptide digests (8 µl each) were injected onto a 1260 Infinity nHPLC stack (Agilent Technologies) and separated using a 75 µm I.D. × 15 cm pulled tip C-18 column (Jupiter C-18 300 Å, 5 µm, Phenomenex). This system runs in-line with a Thermo Orbitrap Velos Pro hybrid mass spectrometer, equipped with a nano-electrospray source (Thermo Fisher Scientific), and all data were collected in CID mode. Searches were performed with a species-specific subset of the UniprotKB database. The list of peptide IDs generated based on SEQUEST (Thermo Fisher Scientific) search results was filtered using Scaffold (Protein Sciences, Portland, OR). Gene ontology assignments and pathway analysis were carried out using MetaCore (GeneGO Inc, St. Joseph, MI). The original dataset has been submitted to Dryad repository (doi:10.5061/dryad.x0k6djhj1).</p></sec><sec id="s3-7"><title>Extracellular flux analysis</title><p>Analyses of cellular bioenergetics were performed using the Seahorse XFe96 Extracellular Flux Analyzer (Agilent, Santa Clara, CA). L-MSCs from young and aged mice were cultured for 24 hr in low serum (1%) containing media. Cells were then detached and replated at a density of 25,000 cells/well into a XF96 microplate 5 hr prior to assay in the same media. After the cells were attached, XF-DMEM media (DMEM supplemented with 5.5 mM glucose, 1 mM pyruvate, and 4 mM L-glutamine, pH 7.4 at 37°C) was added to the wells, and cells were incubated for 1 hr prior to assay in a non-CO<sub>2</sub> incubator at 37°C. Mitochondrial stress test, a parallel measure of basal OCR and ECAR, was carried out following sequential injections of oligomycin (1 µg/ml), carbonyl cyanide 4-(trifluoromethoxy) phenylhydrazone (FCCP [0.6 µM]), antimycin-A (10 µM), and 2-deoxyglucose (50 µM).</p></sec><sec id="s3-8"><title>ATP/ADP ratio</title><p>This assay was performed using an ADP/ATP ratio assay kit (Abcam) following the manufacturer’s instructions.</p></sec><sec id="s3-9"><title>H<sub>2</sub>O<sub>2</sub>-release assay</title><p>This assay was performed based on protocol developed in our laboratory for quantitative measurement of extracellular H<sub>2</sub>O<sub>2</sub> release from adherent fibroblasts (<xref ref-type="bibr" rid="bib27">Thannickal and Fanburg, 1995</xref>). This fluorimetric method relies on the oxidative conversion of homovanillic acid (HVA), a substituted phenolic compound, to its fluorescent dimer in the presence of H<sub>2</sub>O<sub>2</sub> and horseradish peroxidase (HRP). For this experiment, 150,000 young, aged, and aged <italic>Nox4<sup>-/+</sup></italic> mouse lung L-MSCs were seeded in 6-well culture dishes. Next day, cells were serum-starved (1%) overnight and treated with either vehicle or 2.5 ng/ml TGF-β1. Media was aspirated after 16 hr post-treatment; cells were washed with 1 ml of HBSS (without calcium and magnesium) and incubated for 2 hr in 1 ml of assay media containing 100 µM HVA and 5 U/ml HRP in HBSS (containing calcium and magnesium). Reactions were stopped adding stop solution and fluorescence was measured in a BioTek microplate reader at excitation and emission maximum of 321 nm and 421 nm, respectively. Extracellular H<sub>2</sub>O<sub>2</sub> release was measured from standard curve generated from a known concentration of H<sub>2</sub>O<sub>2</sub>. The data are normalized to cell number, and H<sub>2</sub>O<sub>2</sub> concentrations are presented as nanomoles/min/10<sup>6</sup> L-MSCs.</p></sec><sec id="s3-10"><title>Quantitative RT-PCR</title><p>Total RNA was isolated from aged and aged <italic>Nox4<sup>-/+</sup></italic> L-MSCs using RNeasy Mini Kit (Qiagen) and reverse transcribed using iScript Reverse Transcription SuperMix for RT- qPCR (Bio-Rad). Real-timePCR reactions were performed using SYBR Green PCR Master Mix (Life Technologies) and gene-specific primer pairs for Nox4 and β-actin (Integrated DNA Technologies; for primer sequences, see Appendix 1—key resources table). Reactions were carried out for 40 cycles (95°C for 15 s, 60°C for 1 min) in a StepOnePlus Real Time PCR System (Life Technologies). Real-time PCR data (2<sup>-ΔΔCt</sup>) is presented as Nox4 mRNA expression normalized to β-actin.</p></sec><sec id="s3-11"><title>Targeted metabolomics</title><p>Concentrations of TCA metabolites in the young and aged L-MSCs were determined by liquid chromatography tandem mass spectrometry (LCMS) following published protocols (<xref ref-type="bibr" rid="bib26">Tan et al., 2014</xref>) with minor modifications. Dry stocks of analytically pure standards were weighed out and solubilized in MilliQ water and further diluted with 50% methanol to a 10 µg/ml stock. This stock was diluted to generate concentrations for standards ranging from 0.5 to 1000 ng/ml. Methanolic sample extracts were dried under nitrogen (N<sub>2</sub>) gas and reconstituted in 100 µl of 50% methanol. Methanolic samples and standards were derivatized by addition of 10 µl 0.1 M O-benzylhydroxylamine hydrochloride (O-BHA) and 10 µl 0.25 M N-(3-dimethylaminopropyl)-N′-ethylcarbodiimide hydrochloride (EDC) at room temperature (RT) for 1 hr. Samples were then transferred to a 13 × 100 mm borosilicate tube for liquid-liquid extraction. Samples were then dried under N<sub>2</sub> gas at RT and were reconstituted in 100 µl of 0.1% formic acid (FA) and transferred to HPLC vials for LCMS analysis. LCMS was carried out with a Prominence HPLC and API 4000 MS. 10 µl of sample was injected onto an Accucore 2.6 µm C18 100 × 2.1 mm column at 40°C for gradient separation. Column eluent was directed to the API 4000 MS operating system, controlled by Analyst 1.6.2 software. Post-acquisition data analysis was carried out using MultiQuant v3.0.3 software. All standard curve regressions were linear with 1/x<sup>2</sup> weighting.</p></sec><sec id="s3-12"><title>Statistical analysis</title><p>Sample size calculation was deemed unnecessary as our study contains no clinical component or in vivo intervention in mice and was therefore not computed. In this study, three cohorts of mice (young, aged, and aged-<italic>Nox4<sup>-/+</sup></italic>), consisting of 3–8 mice per cohort, were used to obtain sufficient quantities of AEC2s and L-MSCs to perform the necessary assays in biological and technical replicates. In this instance, each mouse in a given cohort was considered a biological replicate, while repeated measurements in cells obtained from each animal were considered technical replicates. Student’s t-test was used to compare between two experimental groups. When more than two experimental groups were present, data were analyzed by multifactor analysis of variance (ANOVA). Pairwise comparisons were performed to identify which paired groups presented significant differences and were adjusted by Tukey’s correction. Data were tested for normality distribution by Shapiro–Wilk test before comparative analysis. Non-normal data (alveolosphere size; <xref ref-type="fig" rid="fig1">Figures 1J</xref> and <xref ref-type="fig" rid="fig4">4K</xref>) were natural log transformed and compared by ANOVA and pairwise comparisons. Differences between the experimental groups were considered significant when p&lt;0.05. All experiments were repeated 2–4 times for reproducibility. Measurement of TCA metabolites was performed only once due to unavailability of age-matched aged <italic>Nox4<sup>-/+</sup></italic>mice in our colony.</p></sec></sec></body><back><sec id="s4" sec-type="additional-information"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interests</title><fn fn-type="COI-statement" id="conf1"><p>none</p></fn><fn fn-type="COI-statement" id="conf2"><p>None</p></fn></fn-group><fn-group content-type="author-contribution"><title>Author contributions</title><fn fn-type="con" id="con1"><p>Conceptualization, Data curation, Formal analysis, Investigation, Methodology, Project administration, Resources, Software, Supervision, Validation, Visualization, Writing – original draft, Writing – review and editing</p></fn><fn fn-type="con" id="con2"><p>Investigation, Software, Writing – review and editing</p></fn><fn fn-type="con" id="con3"><p>Data curation, Formal analysis, Software, Writing – review and editing</p></fn><fn fn-type="con" id="con4"><p>Investigation, Writing – review and editing</p></fn><fn fn-type="con" id="con5"><p>Investigation</p></fn><fn fn-type="con" id="con6"><p>Methodology, Writing – review and editing</p></fn><fn fn-type="con" id="con7"><p>Methodology, Resources</p></fn><fn fn-type="con" id="con8"><p>Formal analysis, Software</p></fn><fn fn-type="con" id="con9"><p>Formal analysis, Investigation, Methodology, Resources</p></fn><fn fn-type="con" id="con10"><p>Formal analysis, Methodology, Resources, Software, Writing – review and editing</p></fn><fn fn-type="con" id="con11"><p>Formal analysis, Methodology, Resources, Software</p></fn><fn fn-type="con" id="con12"><p>Data curation, Formal analysis, Resources, Supervision, Writing – review and editing</p></fn><fn fn-type="con" id="con13"><p>Formal analysis, Resources, Writing – review and editing</p></fn><fn fn-type="con" id="con14"><p>Writing – review and editing</p></fn><fn fn-type="con" id="con15"><p>Resources, Writing – review and editing</p></fn><fn fn-type="con" id="con16"><p>Writing – review and editing</p></fn><fn fn-type="con" id="con17"><p>Conceptualization, Funding acquisition, Project administration, Resources, Supervision, Visualization, Writing – original draft, Writing – review and editing</p></fn></fn-group><fn-group content-type="ethics-information"><title>Ethics</title><fn fn-type="other"><p>This study was performed in strict accordance with the recommendations in the Guide for the Care and Use of Laboratory Animals of the National Institutes of Health. All of the animals were handled according to approved institutional animal care and use committee (IACUC) protocols (#10105) of the University of Alabama at Birmingham. Mice were euthanized under isoflurane anesthesia before isolation of cells. Every effort was made to minimize suffering.</p></fn></fn-group></sec><sec id="s5" sec-type="supplementary-material"><title>Additional files</title><supplementary-material id="supp1"><label>Supplementary file 1.</label><caption><title>Gene Ontology localizations, processes, and network analyses of mass spectrometry data.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-68049-supp1-v1.xlsx"/></supplementary-material><supplementary-material id="transrepform"><label>Transparent reporting form</label><media mime-subtype="docx" mimetype="application" xlink:href="elife-68049-transrepform1-v1.docx"/></supplementary-material></sec><sec id="s6" sec-type="data-availability"><title>Data availability</title><p>Datasets associated with this article have been made available on Dryad (<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.5061/dryad.x0k6djhj1">https://doi.org/10.5061/dryad.x0k6djhj1</ext-link>).</p><p>The following dataset was generated:</p><p><element-citation id="dataset1" publication-type="data" specific-use="isSupplementedBy"><person-group person-group-type="author"><name><surname>Chanda</surname><given-names>D</given-names></name></person-group><year iso-8601-date="2021">2021</year><data-title>Data from: Discovery proteomics by mass spectrometry comparing secreted proteins from young and old mouse lung mesenchymal stromal cells</data-title><source>Dryad Digital Repository</source><pub-id pub-id-type="doi">10.5061/dryad.x0k6djhj1</pub-id></element-citation></p></sec><ack id="ack"><title>Acknowledgements</title><p>We thank Dr. Tingting Yuan for assistance with preparing paraffin blocks and cutting histological sections. We thank Dr. Robert Grabski and Mr. Shawn Williams for their assistance with confocal imaging at the High Resolution Imaging Facility at the University of Alabama at Birmingham (UAB). We also thank Dr. Stephen Barnes, Dr. Landon Wilson, and Mr. Taylor Berryhill at the Targeted Proteomics &amp; Metabolomics Lab, UAB, for their assistance with measuring TCA cycle metabolites. This work was supported by NIH grants P01 HL114470, R01 AG046210, and R01 HL152246; and by VA Merit Award I01BX003056 (to VJT). DC is supported by NIH/NHLBI grant R01 HL139617 (to JZ and VJT); JAM is supported by NIH/NCI grant P30 CA013148; JSD is supported by NIH grants R01 HL128502 and P42 ES027723.</p></ack><ref-list><title>References</title><ref id="bib1"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Baker</surname><given-names>DJ</given-names></name><name><surname>Childs</surname><given-names>BG</given-names></name><name><surname>Durik</surname><given-names>M</given-names></name><name><surname>Wijers</surname><given-names>ME</given-names></name><name><surname>Sieben</surname><given-names>CJ</given-names></name><name><surname>Zhong</surname><given-names>J</given-names></name><name><surname>Saltness</surname><given-names>RA</given-names></name><name><surname>Jeganathan</surname><given-names>KB</given-names></name><name><surname>Verzosa</surname><given-names>GC</given-names></name><name><surname>Pezeshki</surname><given-names>A</given-names></name><name><surname>Khazaie</surname><given-names>K</given-names></name><name><surname>Miller</surname><given-names>JD</given-names></name><name><surname>van Deursen</surname><given-names>JM</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Naturally occurring p16(Ink4a)-positive cells shorten healthy lifespan</article-title><source>Nature</source><volume>530</volume><fpage>184</fpage><lpage>189</lpage><pub-id pub-id-type="doi">10.1038/nature16932</pub-id><pub-id pub-id-type="pmid">26840489</pub-id></element-citation></ref><ref id="bib2"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Barkauskas</surname><given-names>CE</given-names></name><name><surname>Cronce</surname><given-names>MJ</given-names></name><name><surname>Rackley</surname><given-names>CR</given-names></name><name><surname>Bowie</surname><given-names>EJ</given-names></name><name><surname>Keene</surname><given-names>DR</given-names></name><name><surname>Stripp</surname><given-names>BR</given-names></name><name><surname>Randell</surname><given-names>SH</given-names></name><name><surname>Noble</surname><given-names>PW</given-names></name><name><surname>Hogan</surname><given-names>BLM</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Type 2 alveolar cells are stem cells in adult lung</article-title><source>The Journal of Clinical Investigation</source><volume>123</volume><fpage>3025</fpage><lpage>3036</lpage><pub-id pub-id-type="doi">10.1172/JCI68782</pub-id><pub-id pub-id-type="pmid">23921127</pub-id></element-citation></ref><ref id="bib3"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Basil</surname><given-names>MC</given-names></name><name><surname>Katzen</surname><given-names>J</given-names></name><name><surname>Engler</surname><given-names>AE</given-names></name><name><surname>Guo</surname><given-names>M</given-names></name><name><surname>Herriges</surname><given-names>MJ</given-names></name><name><surname>Kathiriya</surname><given-names>JJ</given-names></name><name><surname>Windmueller</surname><given-names>R</given-names></name><name><surname>Ysasi</surname><given-names>AB</given-names></name><name><surname>Zacharias</surname><given-names>WJ</given-names></name><name><surname>Chapman</surname><given-names>HA</given-names></name><name><surname>Kotton</surname><given-names>DN</given-names></name><name><surname>Rock</surname><given-names>JR</given-names></name><name><surname>Snoeck</surname><given-names>H-W</given-names></name><name><surname>Vunjak-Novakovic</surname><given-names>G</given-names></name><name><surname>Whitsett</surname><given-names>JA</given-names></name><name><surname>Morrisey</surname><given-names>EE</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>The Cellular and Physiological Basis for Lung Repair and Regeneration: Past, Present, and Future</article-title><source>Cell Stem Cell</source><volume>26</volume><fpage>482</fpage><lpage>502</lpage><pub-id pub-id-type="doi">10.1016/j.stem.2020.03.009</pub-id><pub-id pub-id-type="pmid">32243808</pub-id></element-citation></ref><ref id="bib4"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bernard</surname><given-names>K</given-names></name><name><surname>Logsdon</surname><given-names>NJ</given-names></name><name><surname>Miguel</surname><given-names>V</given-names></name><name><surname>Benavides</surname><given-names>GA</given-names></name><name><surname>Zhang</surname><given-names>J</given-names></name><name><surname>Carter</surname><given-names>AB</given-names></name><name><surname>Darley-Usmar</surname><given-names>VM</given-names></name><name><surname>Thannickal</surname><given-names>VJ</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>NADPH Oxidase 4 (Nox4) Suppresses Mitochondrial Biogenesis and Bioenergetics in Lung Fibroblasts via a Nuclear Factor Erythroid-derived 2-like 2 (Nrf2)-dependent Pathway</article-title><source>The Journal of Biological Chemistry</source><volume>292</volume><fpage>3029</fpage><lpage>3038</lpage><pub-id pub-id-type="doi">10.1074/jbc.M116.752261</pub-id><pub-id pub-id-type="pmid">28049732</pub-id></element-citation></ref><ref id="bib5"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bertoncello</surname><given-names>I</given-names></name><name><surname>Mcqualter</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Isolation and clonal assay of adult lung epithelial stem/progenitor cells</article-title><source>Curr Protoc Stem Cell Biol</source><volume>2</volume><elocation-id>sc02g01s16</elocation-id><pub-id pub-id-type="doi">10.1002/9780470151808.sc02g01s16</pub-id></element-citation></ref><ref id="bib6"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chatterjee</surname><given-names>A</given-names></name><name><surname>Georgiev</surname><given-names>G</given-names></name><name><surname>Iannacchione</surname><given-names>G</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Aging and efficiency in living systems: Complexity, adaptation and self-organization</article-title><source>Mechanisms of Ageing and Development</source><volume>163</volume><fpage>2</fpage><lpage>7</lpage><pub-id pub-id-type="doi">10.1016/j.mad.2017.02.009</pub-id><pub-id pub-id-type="pmid">28267566</pub-id></element-citation></ref><ref id="bib7"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dimri</surname><given-names>GP</given-names></name><name><surname>Lee</surname><given-names>X</given-names></name><name><surname>Basile</surname><given-names>G</given-names></name><name><surname>Acosta</surname><given-names>M</given-names></name><name><surname>Scott</surname><given-names>G</given-names></name><name><surname>Roskelley</surname><given-names>C</given-names></name><name><surname>Medrano</surname><given-names>EE</given-names></name><name><surname>Linskens</surname><given-names>M</given-names></name><name><surname>Rubelj</surname><given-names>I</given-names></name><name><surname>Pereira-Smith</surname><given-names>O</given-names></name></person-group><year iso-8601-date="1995">1995</year><article-title>A biomarker that identifies senescent human cells in culture and in aging skin in vivo</article-title><source>PNAS</source><volume>92</volume><fpage>9363</fpage><lpage>9367</lpage><pub-id pub-id-type="doi">10.1073/pnas.92.20.9363</pub-id><pub-id pub-id-type="pmid">7568133</pub-id></element-citation></ref><ref id="bib8"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Finkel</surname><given-names>T</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>The metabolic regulation of aging</article-title><source>Nature Medicine</source><volume>21</volume><fpage>1416</fpage><lpage>1423</lpage><pub-id pub-id-type="doi">10.1038/nm.3998</pub-id><pub-id pub-id-type="pmid">26646498</pub-id></element-citation></ref><ref id="bib9"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Georgakopoulou</surname><given-names>EA</given-names></name><name><surname>Tsimaratou</surname><given-names>K</given-names></name><name><surname>Evangelou</surname><given-names>K</given-names></name><name><surname>Fernandez Marcos</surname><given-names>PJ</given-names></name><name><surname>Zoumpourlis</surname><given-names>V</given-names></name><name><surname>Trougakos</surname><given-names>IP</given-names></name><name><surname>Kletsas</surname><given-names>D</given-names></name><name><surname>Bartek</surname><given-names>J</given-names></name><name><surname>Serrano</surname><given-names>M</given-names></name><name><surname>Gorgoulis</surname><given-names>VG</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Specific lipoFuscin staining as a novel biomarker to detect replicative and stress-induced senescence. A method applicable in cryo-preserved and archival tissues</article-title><source>Aging</source><volume>5</volume><fpage>37</fpage><lpage>50</lpage><pub-id pub-id-type="doi">10.18632/aging.100527</pub-id><pub-id pub-id-type="pmid">23449538</pub-id></element-citation></ref><ref id="bib10"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hecker</surname><given-names>L</given-names></name><name><surname>Vittal</surname><given-names>R</given-names></name><name><surname>Jones</surname><given-names>T</given-names></name><name><surname>Jagirdar</surname><given-names>R</given-names></name><name><surname>Luckhardt</surname><given-names>TR</given-names></name><name><surname>Horowitz</surname><given-names>JC</given-names></name><name><surname>Pennathur</surname><given-names>S</given-names></name><name><surname>Martinez</surname><given-names>FJ</given-names></name><name><surname>Thannickal</surname><given-names>VJ</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>NADPH oxidase-4 mediates myofibroblast activation and fibrogenic responses to lung injury</article-title><source>Nature Medicine</source><volume>15</volume><fpage>1077</fpage><lpage>1081</lpage><pub-id pub-id-type="doi">10.1038/nm.2005</pub-id><pub-id pub-id-type="pmid">19701206</pub-id></element-citation></ref><ref id="bib11"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hogan</surname><given-names>BLM</given-names></name><name><surname>Barkauskas</surname><given-names>CE</given-names></name><name><surname>Chapman</surname><given-names>HA</given-names></name><name><surname>Epstein</surname><given-names>JA</given-names></name><name><surname>Jain</surname><given-names>R</given-names></name><name><surname>Hsia</surname><given-names>CCW</given-names></name><name><surname>Niklason</surname><given-names>L</given-names></name><name><surname>Calle</surname><given-names>E</given-names></name><name><surname>Le</surname><given-names>A</given-names></name><name><surname>Randell</surname><given-names>SH</given-names></name><name><surname>Rock</surname><given-names>J</given-names></name><name><surname>Snitow</surname><given-names>M</given-names></name><name><surname>Krummel</surname><given-names>M</given-names></name><name><surname>Stripp</surname><given-names>BR</given-names></name><name><surname>Vu</surname><given-names>T</given-names></name><name><surname>White</surname><given-names>ES</given-names></name><name><surname>Whitsett</surname><given-names>JA</given-names></name><name><surname>Morrisey</surname><given-names>EE</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Repair and regeneration of the respiratory system: Complexity, plasticity, and mechanisms of lung stem cell function</article-title><source>Cell Stem Cell</source><volume>15</volume><fpage>123</fpage><lpage>138</lpage><pub-id pub-id-type="doi">10.1016/j.stem.2014.07.012</pub-id><pub-id pub-id-type="pmid">25105578</pub-id></element-citation></ref><ref id="bib12"><element-citation publication-type="software"><person-group person-group-type="author"><name><surname>Johannes</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2021">2021</year><data-title>Imagej1</data-title><version designator="1b23245">1b23245</version><source>Github</source><ext-link ext-link-type="uri" xlink:href="https://github.com/imagej/imagej1">https://github.com/imagej/imagej1</ext-link></element-citation></ref><ref id="bib13"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kennedy</surname><given-names>BK</given-names></name><name><surname>Berger</surname><given-names>SL</given-names></name><name><surname>Brunet</surname><given-names>A</given-names></name><name><surname>Campisi</surname><given-names>J</given-names></name><name><surname>Cuervo</surname><given-names>AM</given-names></name><name><surname>Epel</surname><given-names>ES</given-names></name><name><surname>Franceschi</surname><given-names>C</given-names></name><name><surname>Lithgow</surname><given-names>GJ</given-names></name><name><surname>Morimoto</surname><given-names>RI</given-names></name><name><surname>Pessin</surname><given-names>JE</given-names></name><name><surname>Rando</surname><given-names>TA</given-names></name><name><surname>Richardson</surname><given-names>A</given-names></name><name><surname>Schadt</surname><given-names>EE</given-names></name><name><surname>Wyss-Coray</surname><given-names>T</given-names></name><name><surname>Sierra</surname><given-names>F</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Geroscience: linking aging to chronic disease</article-title><source>Cell</source><volume>159</volume><fpage>709</fpage><lpage>713</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2014.10.039</pub-id><pub-id pub-id-type="pmid">25417146</pub-id></element-citation></ref><ref id="bib14"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kiss</surname><given-names>HJM</given-names></name><name><surname>Mihalik</surname><given-names>A</given-names></name><name><surname>Nánási</surname><given-names>T</given-names></name><name><surname>Ory</surname><given-names>B</given-names></name><name><surname>Spiró</surname><given-names>Z</given-names></name><name><surname>Soti</surname><given-names>C</given-names></name><name><surname>Csermely</surname><given-names>P</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Ageing as a price of cooperation and complexity: self-organization of complex systems causes the gradual deterioration of constituent networks</article-title><source>BioEssays</source><volume>31</volume><fpage>651</fpage><lpage>664</lpage><pub-id pub-id-type="doi">10.1002/bies.200800224</pub-id><pub-id pub-id-type="pmid">19444836</pub-id></element-citation></ref><ref id="bib15"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Krishnamurthy</surname><given-names>J</given-names></name><name><surname>Torrice</surname><given-names>C</given-names></name><name><surname>Ramsey</surname><given-names>MR</given-names></name><name><surname>Kovalev</surname><given-names>GI</given-names></name><name><surname>Al-Regaiey</surname><given-names>K</given-names></name><name><surname>Su</surname><given-names>L</given-names></name><name><surname>Sharpless</surname><given-names>NE</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>Ink4a/arf expression is a biomarker of aging</article-title><source>The Journal of Clinical Investigation</source><volume>114</volume><fpage>1299</fpage><lpage>1307</lpage><pub-id pub-id-type="doi">10.1172/JCI22475</pub-id><pub-id pub-id-type="pmid">15520862</pub-id></element-citation></ref><ref id="bib16"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lambeth</surname><given-names>JD</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Nox enzymes, ROS, and chronic disease: an example of antagonistic pleiotropy</article-title><source>Free Radical Biology &amp; Medicine</source><volume>43</volume><fpage>332</fpage><lpage>347</lpage><pub-id pub-id-type="doi">10.1016/j.freeradbiomed.2007.03.027</pub-id><pub-id pub-id-type="pmid">17602948</pub-id></element-citation></ref><ref id="bib17"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>López-Otín</surname><given-names>C</given-names></name><name><surname>Blasco</surname><given-names>MA</given-names></name><name><surname>Partridge</surname><given-names>L</given-names></name><name><surname>Serrano</surname><given-names>M</given-names></name><name><surname>Kroemer</surname><given-names>G</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>The hallmarks of aging</article-title><source>Cell</source><volume>153</volume><fpage>1194</fpage><lpage>1217</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2013.05.039</pub-id><pub-id pub-id-type="pmid">23746838</pub-id></element-citation></ref><ref id="bib18"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>López-Otín</surname><given-names>C</given-names></name><name><surname>Galluzzi</surname><given-names>L</given-names></name><name><surname>Freije</surname><given-names>JMP</given-names></name><name><surname>Madeo</surname><given-names>F</given-names></name><name><surname>Kroemer</surname><given-names>G</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Metabolic control of longevity</article-title><source>Cell</source><volume>166</volume><fpage>802</fpage><lpage>821</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2016.07.031</pub-id><pub-id pub-id-type="pmid">27518560</pub-id></element-citation></ref><ref id="bib19"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ludwig</surname><given-names>MR</given-names></name><name><surname>Kojima</surname><given-names>K</given-names></name><name><surname>Bowersock</surname><given-names>GJ</given-names></name><name><surname>Chen</surname><given-names>D</given-names></name><name><surname>Jhala</surname><given-names>NC</given-names></name><name><surname>Buchsbaum</surname><given-names>DJ</given-names></name><name><surname>Grizzle</surname><given-names>WE</given-names></name><name><surname>Klug</surname><given-names>CA</given-names></name><name><surname>Mobley</surname><given-names>JA</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Surveying the serologic proteome in a tissue-specific kras(G12D) knockin mouse model of pancreatic cancer</article-title><source>Proteomics</source><volume>16</volume><fpage>516</fpage><lpage>531</lpage><pub-id pub-id-type="doi">10.1002/pmic.201500133</pub-id><pub-id pub-id-type="pmid">26572242</pub-id></element-citation></ref><ref id="bib20"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sanders</surname><given-names>YY</given-names></name><name><surname>Liu</surname><given-names>H</given-names></name><name><surname>Liu</surname><given-names>G</given-names></name><name><surname>Thannickal</surname><given-names>VJ</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Epigenetic mechanisms regulate nadph oxidase-4 expression in cellular senescence</article-title><source>Free Radical Biology &amp; Medicine</source><volume>79</volume><fpage>197</fpage><lpage>205</lpage><pub-id pub-id-type="doi">10.1016/j.freeradbiomed.2014.12.008</pub-id><pub-id pub-id-type="pmid">25526894</pub-id></element-citation></ref><ref id="bib21"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schulte</surname><given-names>H</given-names></name><name><surname>Mühlfeld</surname><given-names>C</given-names></name><name><surname>Brandenberger</surname><given-names>C</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Age-related structural and functional changes in the mouse lung</article-title><source>Frontiers in Physiology</source><volume>10</volume><elocation-id>1466</elocation-id><pub-id pub-id-type="doi">10.3389/fphys.2019.01466</pub-id><pub-id pub-id-type="pmid">31866873</pub-id></element-citation></ref><ref id="bib22"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schultz</surname><given-names>MB</given-names></name><name><surname>Sinclair</surname><given-names>DA</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>When stem cells grow old: Phenotypes and mechanisms of stem cell aging</article-title><source>Development</source><volume>143</volume><fpage>3</fpage><lpage>14</lpage><pub-id pub-id-type="doi">10.1242/dev.130633</pub-id><pub-id pub-id-type="pmid">26732838</pub-id></element-citation></ref><ref id="bib23"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sies</surname><given-names>H</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Hydrogen peroxide as a central redox signaling molecule in physiological oxidative stress: Oxidative eustress</article-title><source>Redox Biology</source><volume>11</volume><fpage>613</fpage><lpage>619</lpage><pub-id pub-id-type="doi">10.1016/j.redox.2016.12.035</pub-id><pub-id pub-id-type="pmid">28110218</pub-id></element-citation></ref><ref id="bib24"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sinha</surname><given-names>M</given-names></name><name><surname>Lowell</surname><given-names>CA</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Isolation of highly pure primary mouse alveolar epithelial type II cells by flow cytometric cell sorting</article-title><source>Bio-Protocol</source><volume>6</volume><elocation-id>BioProtoc.2013</elocation-id><pub-id pub-id-type="doi">10.21769/BioProtoc.2013</pub-id><pub-id pub-id-type="pmid">28180137</pub-id></element-citation></ref><ref id="bib25"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sun</surname><given-names>N</given-names></name><name><surname>Youle</surname><given-names>RJ</given-names></name><name><surname>Finkel</surname><given-names>T</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>The mitochondrial basis of aging</article-title><source>Molecular Cell</source><volume>61</volume><fpage>654</fpage><lpage>666</lpage><pub-id pub-id-type="doi">10.1016/j.molcel.2016.01.028</pub-id><pub-id pub-id-type="pmid">26942670</pub-id></element-citation></ref><ref id="bib26"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tan</surname><given-names>B</given-names></name><name><surname>Lu</surname><given-names>Z</given-names></name><name><surname>Dong</surname><given-names>S</given-names></name><name><surname>Zhao</surname><given-names>G</given-names></name><name><surname>Kuo</surname><given-names>M-S</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Derivatization of the tricarboxylic acid intermediates with o-benzylhydroxylamine for liquid chromatography-tandem mass spectrometry detection</article-title><source>Analytical Biochemistry</source><volume>465</volume><fpage>134</fpage><lpage>147</lpage><pub-id pub-id-type="doi">10.1016/j.ab.2014.07.027</pub-id><pub-id pub-id-type="pmid">25102203</pub-id></element-citation></ref><ref id="bib27"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Thannickal</surname><given-names>VJ</given-names></name><name><surname>Fanburg</surname><given-names>BL</given-names></name></person-group><year iso-8601-date="1995">1995</year><article-title>Activation of an h2o2-generating NADH oxidase in human lung fibroblasts by transforming growth factor beta 1</article-title><source>The Journal of Biological Chemistry</source><volume>270</volume><fpage>30334</fpage><lpage>30338</lpage><pub-id pub-id-type="doi">10.1074/jbc.270.51.30334</pub-id><pub-id pub-id-type="pmid">8530457</pub-id></element-citation></ref><ref id="bib28"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Thannickal</surname><given-names>VJ</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Aging, antagonistic pleiotropy and fibrotic disease</article-title><source>The International Journal of Biochemistry &amp; Cell Biology</source><volume>42</volume><fpage>1398</fpage><lpage>1400</lpage><pub-id pub-id-type="doi">10.1016/j.biocel.2010.05.010</pub-id><pub-id pub-id-type="pmid">20595011</pub-id></element-citation></ref><ref id="bib29"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Thannickal</surname><given-names>VJ</given-names></name><name><surname>Zhou</surname><given-names>Y</given-names></name><name><surname>Gaggar</surname><given-names>A</given-names></name><name><surname>Duncan</surname><given-names>SR</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Fibrosis: Ultimate and proximate causes</article-title><source>The Journal of Clinical Investigation</source><volume>124</volume><fpage>4673</fpage><lpage>4677</lpage><pub-id pub-id-type="doi">10.1172/JCI74368</pub-id><pub-id pub-id-type="pmid">25365073</pub-id></element-citation></ref><ref id="bib30"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vittal</surname><given-names>R</given-names></name><name><surname>Horowitz</surname><given-names>JC</given-names></name><name><surname>Moore</surname><given-names>BB</given-names></name><name><surname>Zhang</surname><given-names>H</given-names></name><name><surname>Martinez</surname><given-names>FJ</given-names></name><name><surname>Toews</surname><given-names>GB</given-names></name><name><surname>Standiford</surname><given-names>TJ</given-names></name><name><surname>Thannickal</surname><given-names>VJ</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>Modulation of prosurvival signaling in fibroblasts by a protein kinase inhibitor protects against fibrotic tissue injury</article-title><source>The American Journal of Pathology</source><volume>166</volume><fpage>367</fpage><lpage>375</lpage><pub-id pub-id-type="doi">10.1016/S0002-9440(10)62260-2</pub-id><pub-id pub-id-type="pmid">15681821</pub-id></element-citation></ref><ref id="bib31"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Watson</surname><given-names>JK</given-names></name><name><surname>Sanders</surname><given-names>P</given-names></name><name><surname>Dunmore</surname><given-names>R</given-names></name><name><surname>Rosignoli</surname><given-names>G</given-names></name><name><surname>Julé</surname><given-names>Y</given-names></name><name><surname>Rawlins</surname><given-names>EL</given-names></name><name><surname>Mustelin</surname><given-names>T</given-names></name><name><surname>May</surname><given-names>R</given-names></name><name><surname>Clarke</surname><given-names>D</given-names></name><name><surname>Finch</surname><given-names>DK</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Distal lung epithelial progenitor cell function declines with age</article-title><source>Scientific Reports</source><volume>10</volume><elocation-id>10490</elocation-id><pub-id pub-id-type="doi">10.1038/s41598-020-66966-y</pub-id><pub-id pub-id-type="pmid">32591591</pub-id></element-citation></ref><ref id="bib32"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>You</surname><given-names>Y</given-names></name><name><surname>Richer</surname><given-names>EJ</given-names></name><name><surname>Huang</surname><given-names>T</given-names></name><name><surname>Brody</surname><given-names>SL</given-names></name></person-group><year iso-8601-date="2002">2002</year><article-title>Growth and differentiation of mouse tracheal epithelial cells: selection of a proliferative population</article-title><source>American Journal of Physiology. Lung Cellular and Molecular Physiology</source><volume>283</volume><elocation-id>L1315</elocation-id><pub-id pub-id-type="doi">10.1152/ajplung.00169.2002</pub-id><pub-id pub-id-type="pmid">12388377</pub-id></element-citation></ref></ref-list><app-group><app id="appendix-1"><title>Appendix 1</title><table-wrap id="keyresource" position="anchor"><label>Appendix 1—key resources table</label><table frame="hsides" rules="groups"><thead><tr><th align="left" valign="bottom">Reagent type (species) or resource</th><th align="left" valign="bottom">Designation</th><th align="left" valign="bottom">Source or reference</th><th align="left" valign="bottom">Identifiers</th><th align="left" valign="bottom">Additional information</th></tr></thead><tbody><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Podoplanin (T1-α) monoclonal PE-Cyanine7</td><td align="left" valign="bottom">eBioscience/Thermo Fisher Scientific</td><td align="left" valign="bottom">RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_2573459">AB_2573459</ext-link></td><td align="left" valign="bottom">Host: Syrian hamster0.125 µg/100 µl</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">CD31 (PECAM-1) FITC</td><td align="left" valign="bottom">eBioscience/Thermo Fisher Scientific</td><td align="left" valign="bottom">RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_465012">AB_465012</ext-link></td><td align="left" valign="bottom">Host: rat1 µg/100 µl</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">CD326 (EpCAM) monoclonal APC-eFluor780</td><td align="left" valign="bottom">eBioscience/Thermo Fisher Scientific</td><td align="left" valign="bottom">RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_2573986">AB_2573986</ext-link></td><td align="left" valign="bottom">Host: rat0.125 µg/100 µl</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">CD24 monoclonal, APC</td><td align="left" valign="bottom">eBioscience/Thermo Fisher Scientific</td><td align="left" valign="bottom">RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_10870773">AB_10870773</ext-link></td><td align="left" valign="bottom">Host: rat0.06 µg/100 µl</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">CD45 monoclonal (30-F11), PE</td><td align="left" valign="bottom">eBioscience/Thermo fisher Scientific</td><td align="left" valign="bottom">RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_465668">AB_465668</ext-link></td><td align="left" valign="bottom">Host: rat0.125 µg/100 µl</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">TER-119 monoclonal, biotin</td><td align="left" valign="bottom">eBioscience/Thermo fisher Scientific</td><td align="left" valign="bottom">RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_466796">AB_466796</ext-link></td><td align="left" valign="bottom">Host: rat1:100</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">CD16/32, clone 2.4G2, biotin</td><td align="left" valign="bottom">BD Biosciences</td><td align="left" valign="bottom">RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_394658">AB_394658</ext-link></td><td align="left" valign="bottom">Host: rat1:100</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">CD104 [346-11A] biotin</td><td align="left" valign="bottom">BioLegend</td><td align="left" valign="bottom">RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_961034">AB_961034</ext-link></td><td align="left" valign="bottom">Host: rat1:100</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">CD31 [MEC13.3] biotin</td><td align="left" valign="bottom">BioLegend</td><td align="left" valign="bottom">RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_312910">AB_312910</ext-link></td><td align="left" valign="bottom">Host: rat1:100</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">CD45, biotin</td><td align="left" valign="bottom">eBioscience/Thermo Fisher Scientific</td><td align="left" valign="bottom">RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_466446">AB_466446</ext-link></td><td align="left" valign="bottom">Host: rat1:100</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Ki-67/MKI67 polyclonal</td><td align="left" valign="bottom">Novus Biologicals</td><td align="left" valign="bottom">RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_10001977">AB_10001977</ext-link></td><td align="left" valign="bottom">Host: rabbit1:100</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Podoplanin polyclonal</td><td align="left" valign="bottom">R&amp;D Systems</td><td align="left" valign="bottom">RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_2268062">AB_2268062</ext-link></td><td align="left" valign="bottom">Host: goat15 µg/ml</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Phospho-histone H2A.X (Ser139)</td><td align="left" valign="bottom">Cell Signaling Technology</td><td align="left" valign="bottom">RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_2118010">AB_2118010</ext-link></td><td align="left" valign="bottom">Host: mouse1:100</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Pro-surfactant protein C (SFTP-C)</td><td align="left" valign="bottom">Millipore Sigma</td><td align="left" valign="bottom">RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_91588">AB_91588</ext-link></td><td align="left" valign="bottom">Host: rabbit1:1000</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Platelet-derived growth factor receptor-α</td><td align="left" valign="bottom">R&amp;D Systems</td><td align="left" valign="bottom">RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_2236897">AB_2236897</ext-link></td><td align="left" valign="bottom">Host: mouse1:50</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom"> α-smooth muscle actin</td><td align="left" valign="bottom">American Research Product</td><td align="left" valign="bottom">RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_1540376">AB_1540376</ext-link></td><td align="left" valign="bottom">Host: mouse1:500</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Goat anti-rabbit IgG secondary antibody-Alexa Fluor 594</td><td align="left" valign="bottom">Thermo Fisher Scientific</td><td align="left" valign="bottom">RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_2556545">AB_2556545</ext-link></td><td align="left" valign="bottom">Host: goat2 µg/ml</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Donkey anti-goat IgG secondary antibody-Alexa Fluor 594</td><td align="left" valign="bottom">Thermo Fisher Scientific</td><td align="left" valign="bottom">RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_2534105">AB_2534105</ext-link></td><td align="left" valign="bottom">Host: donkey2 µg/ml</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Donkey anti-mouse IgG secondary antibody-Alexa Fluor 594</td><td align="left" valign="bottom">Thermo Fisher Scientific</td><td align="left" valign="bottom">RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_2556543">AB_2556543</ext-link></td><td align="left" valign="bottom">Host: donkey2 µg/ml</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Donkey anti-rabbit IgG secondary antibody-Alexa Fluor 488</td><td align="left" valign="bottom">Thermo Fisher Scientific</td><td align="left" valign="bottom">RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_2556546">AB_2556546</ext-link></td><td align="left" valign="bottom">Host: donkey2 µg/ml</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-Biotin MicroBeads UltraPure</td><td align="left" valign="bottom">Miltenyi Biotec</td><td align="left" valign="bottom">AB_2811216</td><td align="left" valign="bottom">Host: mouse</td></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">Fluorescent cell staining reagents</td><td align="left" valign="bottom">Fixable Viability Dye eFluor 450</td><td align="left" valign="bottom">eBioscience/Thermo Fisher Scientific</td><td align="left" valign="bottom"> </td></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">Fluorescent cell staining reagents</td><td align="left" valign="bottom">Phalloidin-iFluor 594 Reagent -CytoPainter</td><td align="left" valign="bottom">Abcam</td><td align="left" valign="bottom"> </td></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">Fluorescent cell staining reagents</td><td align="left" valign="bottom">Hoechst 33342trihydrochloride trihydrate</td><td align="left" valign="bottom">Thermo Fisher Scientific</td><td align="left" valign="bottom"> </td></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">Bovine pituitary extract</td><td align="left" valign="bottom">Millipore Sigma</td><td align="left" valign="bottom">P1476-2.5ML</td><td align="left" valign="bottom">MTEC/plus supplement</td></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">Collagenase, type 4</td><td align="left" valign="bottom">Worthington Biochemical</td><td align="left" valign="bottom">LS004188</td><td align="left" valign="bottom">L-MSC isolation</td></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">Dispase II</td><td align="left" valign="bottom">Millipore Sigma</td><td align="char" char="." valign="bottom">4942078001</td><td align="left" valign="bottom">AEC2 isolation</td></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">Matrigel MembraneMatrix GFR</td><td align="left" valign="bottom">Corning</td><td align="char" char="." valign="bottom">356231</td><td align="left" valign="bottom">Alveolosphere assay</td></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">Insulin-transferrin-selenium-ethanolamine (ITS -X) (100X)</td><td align="left" valign="bottom">Thermo Fisher Scientific</td><td align="char" char="." valign="bottom">51500056</td><td align="left" valign="bottom">MTEC/plus supplement</td></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">Human insulin soln.</td><td align="left" valign="bottom">Millipore Sigma</td><td align="left" valign="bottom">I9278-5ML</td><td align="left" valign="bottom">MTEC/plus supplement</td></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">EGF recombinantmouse protein</td><td align="left" valign="bottom">Thermo Fisher Scientific</td><td align="left" valign="bottom">PMG8041</td><td align="left" valign="bottom">MTEC/plus supplement</td></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">STEMRD Y27632ROCK inhibitor</td><td align="left" valign="bottom">Thermo Fisher Scientific</td><td align="char" char="hyphen" valign="bottom">50-175-997</td><td align="left" valign="bottom">MTEC/plus supplement</td></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">All-trans retinoic acid</td><td align="left" valign="bottom">Millipore Sigma</td><td align="left" valign="bottom">R2625-100MG</td><td align="left" valign="bottom">MTEC/plus supplement</td></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">Cholera toxin</td><td align="left" valign="bottom">Millipore Sigma</td><td align="left" valign="bottom">C8052-5MG</td><td align="left" valign="bottom">MTEC/plus supplement</td></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">Recombinant humanTGF-beta1</td><td align="left" valign="bottom">PeproTech</td><td align="char" char="hyphen" valign="bottom">100-21-2ug</td><td align="left" valign="bottom"> </td></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">Horseradish peroxidase</td><td align="left" valign="bottom">Millipore Sigma</td><td align="left" valign="bottom">P8375-25KU</td><td align="left" valign="bottom"> </td></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">Homovanillic acid,fluorimetric reagent</td><td align="left" valign="bottom">Millipore Sigma</td><td align="left" valign="bottom">H1252-100MG</td><td align="left" valign="bottom"> </td></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">Hydrogen peroxide solution, 30% (w/w)</td><td align="left" valign="bottom">Millipore Sigma</td><td align="left" valign="bottom">H1009-100ML</td><td align="left" valign="bottom"> </td></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">Oligomycin</td><td align="left" valign="bottom">Millipore Sigma</td><td align="left" valign="bottom">O4876-5MG</td><td align="left" valign="bottom"> </td></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">Carbonyl cyanide 4</td><td align="left" valign="bottom">Millipore Sigma</td><td align="left" valign="bottom">C2920-10MG</td><td align="left" valign="bottom"> </td></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">Antimycin A</td><td align="left" valign="bottom">Millipore Sigma</td><td align="left" valign="bottom">A8674-25MG</td><td align="left" valign="bottom"> </td></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">2-deoxy D-glucose</td><td align="left" valign="bottom">Millipore Sigma</td><td align="left" valign="bottom">D6134-5G</td><td align="left" valign="bottom"> </td></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">Vectashield</td><td align="left" valign="bottom">Vector Laboratories</td><td align="left" valign="bottom">H-1400-10</td><td align="left" valign="bottom"> </td></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">HistoGel; specimenprocessing gel</td><td align="left" valign="bottom">Richard-Allan Scientific/Thermo Fisher Scientific</td><td align="left" valign="bottom">HG-4000-012</td><td align="left" valign="bottom"> </td></tr><tr><td align="left" valign="bottom">Commercial assay or kit</td><td align="left" valign="bottom">Pierce BCA ProteinAssay Kit</td><td align="left" valign="bottom">Thermo Fisher Scientific</td><td align="left" valign="bottom">PI23225</td><td align="left" valign="bottom"> </td></tr><tr><td align="left" valign="bottom">Commercial assay or kit</td><td align="left" valign="bottom">EZQ Protein Quantitation Kit</td><td align="left" valign="bottom">Thermo Fisher Scientific</td><td align="left" valign="bottom">R33200</td><td align="left" valign="bottom"> </td></tr><tr><td align="left" valign="bottom">Commercial assay or kit</td><td align="left" valign="bottom">MidiMACS Starting Kit (LS)</td><td align="left" valign="bottom">Miltenyi Biotec</td><td align="char" char="hyphen" valign="bottom">130-042-301</td><td align="left" valign="bottom"> </td></tr><tr><td align="left" valign="bottom">Commercial assay or kit</td><td align="left" valign="bottom">Senescence DetectionKit</td><td align="left" valign="bottom">Abcam</td><td align="left" valign="bottom">Ab65351</td><td align="left" valign="bottom"> </td></tr><tr><td align="left" valign="bottom">Commercial assay or kit</td><td align="left" valign="bottom">Mouse XL Cytokine Array Kit</td><td align="left" valign="bottom">R&amp;D Systems</td><td align="left" valign="bottom">ARY028</td><td align="left" valign="bottom"> </td></tr><tr><td align="left" valign="bottom">Commercial assay or kit</td><td align="left" valign="bottom">ADP/ATP Ratio Kit</td><td align="left" valign="bottom">Abcam</td><td align="left" valign="bottom">Ab65313</td><td align="left" valign="bottom"> </td></tr><tr><td align="left" valign="bottom">Commercial assay or kit</td><td align="left" valign="bottom">Novex Colloidal Blue Staining kit</td><td align="left" valign="bottom">Invitrogen</td><td align="left" valign="bottom">LC6025</td><td align="left" valign="bottom"> </td></tr><tr><td align="left" valign="bottom">Strain, strain background (<italic>Mus musculus</italic>)</td><td align="left" valign="bottom">C57BL/6J (2 months) male</td><td align="left" valign="bottom">Jackson Laboratory</td><td align="left" valign="bottom">IMSR_JAX:000664</td><td align="left" valign="bottom"> </td></tr><tr><td align="left" valign="bottom">Strain, strain background (<italic>Mus musculus</italic>)</td><td align="left" valign="bottom">C57BL/6J (18 months) male</td><td align="left" valign="bottom">National Institute of Aging</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom"> </td></tr><tr><td align="left" valign="bottom">Strain, strain background (<italic>Mus musculus</italic>)</td><td align="left" valign="bottom">C57BL/6J (Nox4 knockout) male</td><td align="left" valign="bottom">Dr. Karl-Heinz Krause</td><td align="left" valign="bottom">University of Geneva</td><td align="left" valign="bottom"> </td></tr><tr><td align="left" valign="bottom">Other</td><td align="left" valign="bottom">Mouse genotyping service</td><td align="left" valign="bottom">Transnetyx, Inc, Cordova, TN</td><td align="left" valign="bottom"/><td align="left" valign="bottom"> </td></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">Isoflurane</td><td align="left" valign="bottom">VetOne</td><td align="left" valign="bottom">NDC 13985-528-60</td><td align="left" valign="bottom">Anesthesia agent</td></tr><tr><td align="left" valign="bottom">Other</td><td align="left" valign="bottom">Inverted microscope</td><td align="left" valign="bottom">Keyence</td><td align="left" valign="bottom">SCR_017202</td><td align="left" valign="bottom"> </td></tr><tr><td align="left" valign="bottom">Other</td><td align="left" valign="bottom">Inverted microscope</td><td align="left" valign="bottom">Carl Zeiss</td><td align="left" valign="bottom"/><td align="left" valign="bottom"> </td></tr><tr><td align="left" valign="bottom">Other</td><td align="left" valign="bottom">Nikon A1R confocal microscope</td><td align="left" valign="bottom">Nikon</td><td align="left" valign="bottom"/><td align="left" valign="bottom"> </td></tr><tr><td align="left" valign="bottom">Other</td><td align="left" valign="bottom">Microplate reader</td><td align="left" valign="bottom">BioTek</td><td align="left" valign="bottom">SynergyMx</td><td align="left" valign="bottom"> </td></tr><tr><td align="left" valign="bottom">Other</td><td align="left" valign="bottom">Centrifuge</td><td align="left" valign="bottom">Eppendorf</td><td align="char" char="." valign="bottom">5702R</td><td align="left" valign="bottom"> </td></tr><tr><td align="left" valign="bottom">Other</td><td align="left" valign="bottom">Flow Cell Sorter</td><td align="left" valign="bottom">BD Biosciences</td><td align="left" valign="bottom"/><td align="left" valign="bottom"> </td></tr><tr><td align="left" valign="bottom">Other</td><td align="left" valign="bottom">BD FACS Aria</td><td align="left" valign="bottom">BD Biosciences</td><td align="left" valign="bottom">SCR_018091</td><td align="left" valign="bottom"> </td></tr><tr><td align="left" valign="bottom">Other</td><td align="left" valign="bottom">Flow Cell Analysis</td><td align="left" valign="bottom">BD Biosciences</td><td align="left" valign="bottom">BD LSR II GUAVA EasyCyte</td><td align="left" valign="bottom"> </td></tr><tr><td align="left" valign="bottom">Other</td><td align="left" valign="bottom">Extracellular Flux Analyzer (Seahorse XFe96)</td><td align="left" valign="bottom">Agilent</td><td align="left" valign="bottom">SCR_019545</td><td align="left" valign="bottom"> </td></tr><tr><td align="left" valign="bottom">Other</td><td align="left" valign="bottom">LS columns (magnetic separation)</td><td align="left" valign="bottom">Miltenyi Biotec</td><td align="char" char="hyphen" valign="bottom">130-042-401</td><td align="left" valign="bottom">AEC2 purification</td></tr><tr><td align="left" valign="bottom">Other</td><td align="left" valign="bottom">Extracellular FluxAnalyzer</td><td align="left" valign="bottom">Agilent</td><td align="left" valign="bottom">Seahorse XFe96</td><td align="left" valign="bottom"> </td></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom">ImageJ</td><td align="left" valign="bottom">Wayne Rasband (NIH)</td><td align="left" valign="bottom"><ext-link ext-link-type="uri" xlink:href="https://github.com/imagej/imagej1">https//github.com/imagej/imagej1</ext-link></td><td align="left" valign="bottom"> <xref ref-type="bibr" rid="bib12">Johannes, 2021</xref></td></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom">Image Quant</td><td align="left" valign="bottom">Cytiva</td><td align="left" valign="bottom">Version TL8.1</td><td align="left" valign="bottom"> </td></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom">FlowJo</td><td align="left" valign="bottom">Tree Star Inc</td><td align="left" valign="bottom"/><td align="left" valign="bottom"> </td></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom">Nis Elements</td><td align="left" valign="bottom">Nikon</td><td align="left" valign="bottom">Version 5.0</td><td align="left" valign="bottom"> </td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">Mouse Nox4 forward</td><td align="left" valign="bottom">IDT</td><td align="left" valign="bottom"><named-content content-type="sequence">ACT TTT CAT TGG GCG TCC TC</named-content></td><td align="left" valign="bottom">RT-PCR</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">Mouse Nox4 reverse</td><td align="left" valign="bottom">IDT</td><td align="left" valign="bottom"><named-content content-type="sequence">AGA ACT GGG TCC ACA GCA GA</named-content></td><td align="left" valign="bottom">RT-PCR</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">Mouse β-actin forward</td><td align="left" valign="bottom">IDT</td><td align="left" valign="bottom"><named-content content-type="sequence">AGT GTG ACG TTG ACA TCC GT</named-content></td><td align="left" valign="bottom">RT-PCR</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">Mouse β-actin reverse</td><td align="left" valign="bottom">IDT</td><td align="left" valign="bottom"><named-content content-type="sequence">TGC TAG GAG CCA GAG CAG TA</named-content></td><td align="left" valign="bottom">RT-PCR</td></tr></tbody></table> </table-wrap></app></app-group></back><sub-article article-type="decision-letter" id="sa1"><front-stub><article-id pub-id-type="doi">10.7554/eLife.68049.sa1</article-id><title-group><article-title>Decision letter</article-title></title-group><contrib-group content-type="section"><contrib contrib-type="editor"><name><surname>Noble</surname><given-names>Paul W</given-names></name><role>Reviewing Editor</role><aff><institution>Cedars-Sinai Medical Centre</institution><country>United States</country></aff></contrib></contrib-group><contrib-group><contrib contrib-type="reviewer"><name><surname>Kass</surname><given-names>Daniel</given-names></name><role>Reviewer</role></contrib></contrib-group></front-stub><body><boxed-text id="box1"><p>In the interests of transparency, eLife publishes the most substantive revision requests and the accompanying author responses.</p></boxed-text><p><bold>Acceptance summary:</bold></p><p>This paper is of interest to a broad audience of lung biology, aging biology, fibrosis and pulmonary medicine. It identified a critical mechanism under which aging of mesenchymal stromal cells deleteriously affect lung alveolar progenitor cell behavior. It employed 3-demensional organoid culture, proteomics, metabolic manipulation, as well as genetically modified mice to support their claims. They build on their previous discovery that oxidative stress is a key regulator of pulmonary fibrosis and that Nox4 is a critical regulator. These studies further support the concept of targeting oxidative stress through Nox4 as a viable therapeutic target in organ fibrosis.</p><p><bold>Decision letter after peer review:</bold></p><p>Thank you for submitting your article &quot;Mesenchymal Stromal Cell Aging Impairs the Self-Organizing Capacity of Lung Alveolar Epithelial Stem Cells&quot; for consideration by <italic>eLife</italic>. Your article has been reviewed by 2 peer reviewers, and the evaluation has been overseen by a Reviewing Editor and Paul Noble as the Senior Editor. The following individual involved in review of your submission has agreed to reveal their identity: Daniel Kass (Reviewer #2).</p><p>The reviewers have discussed their reviews with one another, and the Reviewing Editor has drafted this to help you prepare a revised submission.</p><p>Essential revisions:</p><p>1) Please respond to the 2 reviewers suggestions to improved the manuscript. Some new data would be helpful where suggested.</p><p><italic>Reviewer #1:</italic></p><p>In this manuscript, Dr. Chanda, Dr. Thannickal, and colleagues investigated the role of lung mesenchymal stromal cell (L-MSC) aging in supporting type 2 alveolar epithelia cells (AEC2s) regeneration using 3D organoid culture. This study addresses very important aspects in aging related lung biology study. It is largely unknown the mechanistic links between niche aging and the stem cell exhaustion in the lung. The authors demonstrated that young L-MSCs supported the efficient alveoloshpere formation of both young and old AEC2s, while the aged L-MSC did not, even with young AEC2s. This study employed 3-dimensional organoid culture, proteomics, metabolic manipulation, as well as genetically modified mice to support their claim that aging of lung mesenchymal stromal cells leads to altered bioenergetics and oxidative stress that impair regenerative capacity of the epithelial stem cells. Some additional studies are suggested below to better strengthen the findings and provide more insight of cell-cell interaction between lung mesenchymal stromal cells type 2 alveolar epithelia cells.</p><p>1. A comparison of cytokines/growth factors or secreted proteins between aged WT L-MSCs and aged Nox4+/- L-MSCs would provide better clue to identify the secreted factors which is crucial for L-MSCs to support AEC2 organoid formation.</p><p>2. Adding H2O2 to the organoid culture of young WT L-MSCs/young AEC2s or aged Nox4+/- L-MSCs/young AEC2s would help to directly demonstrate whether Nox-4- dependent oxidative stress of L-MSCs is associated with impaired AEC2 organoid formation.</p><p>3. An experiment to test the effect of Nox-4 inhibitor on AEC2 organoid formation with Old WT L-MSCs would be informative.</p><p>4. In Figure 4G, it would be great is the authors include the culture of Nox-4- L-MSCs with old AEC2s to test if Nox-4- L-MSCs are also better in supporting old AEC2s renewal.</p><p>5. Some discussion should be added to explain how the metabolic dysregulation of aged L-MSCs links to the supportive function of the cells to AEC2 organoid formation.</p><p><italic>Reviewer #2:</italic></p><p>I have been asked to review by Drs Chanda and colleagues which reports a very interesting phenotype-the failure of aged lung mesenchymal stem cells to support alveolospheres. The team, which is well-suited to an analysis of senescence, found that aged lung MSCs exhibit altered bioenergetics compared to young L-MSCs. Altered energetics were associated with changes in the secretome of these cells reflecting many of the classical SASP. The aged MSCs express H2O2 which is associated with activation of Nox4. The team found that the phenotype on alveolospheres could be rescued with Nox4+/- aged MSCs. In general the manuscript is well-written and shares a very important message about the role of the mesenchymal compartment in regulating lung epithelial cell growth and differentiation.</p><p>The implications here are that an aging mesenchymal compartment in the lungs of older patients are unable to support epithelial cell repair. In the context of pulmonary fibrosis, these data also suggest that fibroblasts are not simply &quot;matrix factories.&quot; They are critical to the maintenance of the gas exchange surface. The authors do not overstate their conclusions, which is scientifically appropriate but these data here do lead to some very exciting speculation about lung injury and repair.</p><p>The authors do show several bioenergetic and secretome changes associated with aging MSCs. These findings do not clearly establish what the critical factors are that support the formation of alveolospheres. This is a limitation of the manuscript. finding that factor or factors may represent finding a needle in a haystack. But the association of Nox4 haploinsufficiency with rescue of the phenotype does point the team in the right direction.</p><p>1. I wonder about some of the critical mesenchyme-derived factors that support lung development like FGF7/10 or Wnts, for example? Does the team have data on these factors? This manuscript suggests that fibroblast-free organoids can form in the presence of these factors: https://www.cell.com/iscience/pdf/S2589-0042(18)30252-9.pdf</p><p>2. Is there any epithelial cell cytotoxicity from the H2O2 generated by the aged stem cells? This may be difficult to tease out from general failure of epithelial cells to form organoids.</p><p>3. In Figure 1I, for example, the analysis should be two-way ANOVA to test a 2x2 experimental design where young/old MSCs and young/old epithelial cells are tested. The two way ANOVA calculation will provide an interaction term which may also be informative. This should apply to all 2x2 designs.</p><p>4. In the statistical analysis section, please identify the method for adjusting for false discovery rate.</p></body></sub-article><sub-article article-type="reply" id="sa2"><front-stub><article-id pub-id-type="doi">10.7554/eLife.68049.sa2</article-id><title-group><article-title>Author response</article-title></title-group></front-stub><body><disp-quote content-type="editor-comment"><p>Reviewer #1:</p><p>In this manuscript, Dr. Chanda, Dr. Thannickal, and colleagues investigated the role of lung mesenchymal stromal cell (L-MSC) aging in supporting type 2 alveolar epithelia cells (AEC2s) regeneration using 3D organoid culture. This study addresses very important aspects in aging related lung biology study. It is largely unknown the mechanistic links between niche aging and the stem cell exhaustion in the lung. The authors demonstrated that young L-MSCs supported the efficient alveoloshpere formation of both young and old AEC2s, while the aged L-MSC did not, even with young AEC2s. This study employed 3-dimensional organoid culture, proteomics, metabolic manipulation, as well as genetically modified mice to support their claim that aging of lung mesenchymal stromal cells leads to altered bioenergetics and oxidative stress that impair regenerative capacity of the epithelial stem cells. Some additional studies are suggested below to better strengthen the findings and provide more insight of cell-cell interaction between lung mesenchymal stromal cells type 2 alveolar epithelia cells.</p></disp-quote><p>Thank you for the positive comments and recognition of the novelty of our studies. We have conducted additional studies as suggested and carefully revised the manuscript with changes highlighted in red, and a point-by-point response follows. We believe these additional studies further strengthen the findings and provide significant new insights into cell-cell interactions in the alveolar stem cell niche.</p><disp-quote content-type="editor-comment"><p>1. A comparison of cytokines/growth factors or secreted proteins between aged WT L-MSCs and aged Nox4+/- L-MSCs would provide better clue to identify the secreted factors which is crucial for L-MSCs to support AEC2 organoid formation.</p></disp-quote><p>Thank you for this suggestion. In new studies, we compared SASP-associated cytokines produced by aged wild-type and aged Nox4<sup>-/+</sup> L-MSCs. Our results indicate that a number of secreted SASP cytokines are modulated by Nox4, and these data are now included in Figure 4—figure supplement 4I. We were unable to identify a group of cytokines (except for Coagulation Factor III) that were specifically identified in the dataset comparing young vs. aged L-MSCs based on the antibody-based cytokine array method. Further studies with an unbiased approach such as that employed by mass spectrometric analyses (Figure 2I) will be required for more in-depth analyses of Nox4 regulated SASP cytokines/growth factors. Additionally, we investigated the effect of Nox4 haploinsufficiency on cellular bioenergetics and senescence of L-MSCs. We observed significant reduction in real-time OCR, including basal, ATP-linked, proton leak, and maximal in aged Nox4-/+ L-MSCs as compared to aged L-MSCs (Figure 4G, H). β-gal activity, a marker of senescence, was also reduced in Nox4 deficient L-MSCs (Figure 4—figure supplement 4H).</p><disp-quote content-type="editor-comment"><p>2. Adding H2O2 to the organoid culture of young WT L-MSCs/young AEC2s or aged Nox4+/- L-MSCs/young AEC2s would help to directly demonstrate whether Nox-4- dependent oxidative stress of L-MSCs is associated with impaired AEC2 organoid formation.</p></disp-quote><p>Thank you. Although it is difficult to mimic the levels of continuous H<sub>2</sub>O<sub>2</sub> production by aged L-MSCs in the alveolosphere model, we evaluated the effects of adding a single dose of H2O2 at a concentration of 1 μM to the organoid culture of young WT L-MSCs/young AEC2s. This resulted in a reduction in alveolosphere size, without affecting alveolar numbers (Figure 4—figure supplement 4, A-C).</p><disp-quote content-type="editor-comment"><p>3. An experiment to test the effect of Nox-4 inhibitor on AEC2 organoid formation with Old WT L-MSCs would be informative.</p></disp-quote><p>As suggested, we have performed new experiments testing the effect of the Nox4 inhibitor, GKT137831 on AEC2 organoid formation with WT aged L-MSCs. Interestingly, we were unable to detect significant differences in both alveolosphere size and number with GKT137831 treatment (Figure 4—figure supplement 4, K-M). It is important to recognize that we have not confirmed that this intervention effectively inhibited Nox4 activity (as this is more difficult to assess in the 3D organoid model). We believe the genetic approach we employed (Figure 4) provides more rigorous evidence that Nox4 effects are critical in niche support of AEC2 function.</p><disp-quote content-type="editor-comment"><p>4. In Figure 4G, it would be great is the authors include the culture of Nox-4- L-MSCs with old AEC2s to test if Nox-4- L-MSCs are also better in supporting old AEC2s renewal.</p></disp-quote><p>Thank you for this insightful suggestion. We did perform the suggested studies and found that aged L-MSCs Nox4<sup>-/+</sup> were incapable of completely rescuing impaired alveolosphere formation when combined with aged AEC2s (Figure 4—figure supplement 4, N-P). The implications of this new data are discussed in the Results and Discussion section. While the phenotype of impaired alveolosphere formation in young AECs/aged MSCs was reversed by haploinsufficiency of Nox4 in the mesenchyme (Figure 4, I-K), this was not sufficient to reverse the phenotype in aged AECs. This finding, along with the observation that WT young L-MSCs are sufficient to reverse the aged AEC phenotype (Figure 1H) suggests that, in addition to reduced expression of Nox4 in aged L-MSCs, the young mesenchyme may support niche function and recovery of alveolosphere formation in aged AEC2s by a Nox4-independent mechanism. Thus, an aging alveolar stem cell niche may involve both a gain of “pro-aging factors” (Nox4) and loss of “rejuvenation factors” by the mesenchyme; the identification of the latter will require further study.</p><disp-quote content-type="editor-comment"><p>5. Some discussion should be added to explain how the metabolic dysregulation of aged L-MSCs links to the supportive function of the cells to AEC2 organoid formation.</p></disp-quote><p>Thank you. We have now added to the Results and Discussion (including the data above) with link to metabolic dysregulation (Figure 4G, H; Figure 4—figure supplement 4H).</p><disp-quote content-type="editor-comment"><p>Reviewer #2:</p><p>1. I wonder about some of the critical mesenchyme-derived factors that support lung development like FGF7/10 or Wnts, for example? Does the team have data on these factors? This manuscript suggests that fibroblast-free organoids can form in the presence of these factors: https://www.cell.com/iscience/pdf/S2589-0042(18)30252-9.pdf</p></disp-quote><p>This is an interesting concept that highlights the complexity of stem cell niche maintenance. Our studies indicate that niche aging may involve both a GAIN of pro-senescent/aging factors and a LOSS of pro-regenerative factors. The relative contributions to these are unknown; however, we do show that suppressing pro-senescent factors (Nox4) was sufficient to recover alveolosphere formation in aged L-MSCs/young AEC2s (but not in aged L-MSCs/aged AEC2s). This may be related to the additional requirement for pro-regenerative (“rejuvenation”) factors in aged AEC2s. Based on the suggestion by the reviewer, we did perform studies with FGF-10 to determine whether alveolosphere formation can be rescued in aged L-MSCs/aged AEC2s. Although some experiments showed significant improvement in organoid formation, we did not get consistent data to be certain that replacing this factor (FGF-10) is sufficient. As discussed above, it is possible that modulation of both LOSS and GAIN components are required for optimal alveolosphere formation.</p><fig id="sa2fig1" position="float"><label>Author response image 1.</label><caption><p>(<bold>A</bold>) Alveolosphere assay. Aged L-MSCs were co-cultured with aged AEC2s in the presence of FGF-10 (100 ng/ml). The alveolospheres were imaged by brightfield microscopy after 12 days of co-culture, and comparative outcomes are shown here (scale bar = 500 μm) (<bold>B</bold>) Alveolospheres in each well were counted. Alveolosphere size (volumes) were determined for each of the 2 co-culture groups. Nested scatterplot showing Mean ± SEM of all the alveolospheres counted in each well for each group (n = 2 mice; **p &lt; 0.01; unpaired T-test). Data were natural log transformed before T-test.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-68049-sa2-fig1-v1.tif"/></fig><disp-quote content-type="editor-comment"><p>2. Is there any epithelial cell cytotoxicity from the H2O2 generated by the aged stem cells? This may be difficult to tease out from general failure of epithelial cells to form organoids.</p></disp-quote><p>We agree. H<sub>2</sub>O<sub>2</sub> may mediate more direct effects by inducing cytotoxicity or induce senescent changes such as activation of a SASP program. As noted in the response to Reviewer 1, addition of a low dose of H<sub>2</sub>O<sub>2</sub> (1 μM) to the organoid culture of young WT L-MSCs/young AEC2s reduced alveolosphere size without a significant change in the number of alveolospheres formed (Figure 4—figure supplement 4, A-C).</p><disp-quote content-type="editor-comment"><p>3. In Figure 1I, for example, the analysis should be two-way ANOVA to test a 2x2 experimental design where young/old MSCs and young/old epithelial cells are tested. The two way ANOVA calculation will provide an interaction term which may also be informative. This should apply to all 2x2 designs.</p></disp-quote><p>Thank you, and we agree. The analysis results presented in Figure 1I and 4J were obtained by performing two-factor ANOVA testing groups including young/aged L-MSCs and young/aged epithelial cells (AEC2s). Statistical analysis section in the manuscript has been revised to clarify these changes.</p><disp-quote content-type="editor-comment"><p>4. In the statistical analysis section, please identify the method for adjusting for false discovery rate.</p></disp-quote><p>The statistical analysis section of the manuscript has been revised to include a description of the method, Tukey’s correction, used for adjusting Type I error for pairwise comparisons.</p></body></sub-article></article>